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ABSTRACT 
 
During the last few decades, Streptomycetes have shown to be an important and 
adaptable group of bacteria for the production of various beneficial secondary metabolites. 
One such secondary metabolite, epsilon polylysine (ε-PL), produced by Streptomyces 
albulus is of particular interest due to its antimicrobial activity.  
This work aimed to study different facets surrounding ε-PL and its production. Firstly, to 
grow S. albulus CCRC 11814, using economically viable crude glycerol as a carbon 
source and subsequently measure ε-PL production using an anionic dye, trypan blue. 
Secondly, to evaluate the antimicrobial activity of ε-PL against Staphylococcus aureus, 
Escherichia coli, Pseudomonas aeruginosa, Aspergillus niger and Penicillium simplissium. 
Thirdly, to determine whether there is economic feasibility of ε-PL as a food preservative 
in South Africa. Lastly, to develop and optimise tools for metabolic engineering such as 
recombineering and group II introns to improve ε-PL production.  
The results obtained in this study fall into three different areas: 
In terms of growth studies, S. albulus grew in the presence of crude glycerol, although the 
growth was suboptimal, 0.48 g/L as compared to 1.04 g/L produced using pure glycerol or 
glucose. This is due to the pressures on the bacteria from the impurities of crude glycerol 
such as methanol and salts. ε-PL antimicrobial activity was effective at a concentration of 
100 μg/ml against S. aureus, E. coli and A. niger. It was however, ineffective against 
P. aeruginosa owing to the low outer membrane permeability of the bacteria.  Due to the 
ability of S. albulus to grow in crude glycerol, it could be used as a financially viable option 
to produce ε-PL as a natural food preservative in South Africa.  
The economic feasibility of ε-PL as a food preservative in South Africa showed potential in 
terms of market research as well as the financial evaluations. However; the production 
volumes are low due to the use of the crude glycerol and may not cater for the large food 
industry in the country. For these reasons, metabolic engineering could be employed to 
improve these production volumes.  
The first step to metabolic engineering was to develop novel tools which can be used for 
genetic modifications in S. albulus. The group II intron tools for gene knockouts were 
developed by the construction of a vector which subsequently requires sequencing and 
testing to perform gene knockouts. Based on current knowledge, this is the first 
experiment of its kind.  In terms of introduction of genetic material post gene knockouts,   
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transformation was shown to be a more effective gene transfer technique as opposed to 
electroporation, producing 7.75 transformants/μg and 0.038 transformants/μg of DNA, 
respectively.  
Future work would involve the use of biocatalysis for metabolic engineering of S. albulus 
by either removing genes inhibiting ε-PL or overexpressing the enzyme responsible for its 
production.  
This research has developed the groundwork for future ε-PL production improvement 
using biocatalysis and economically viable crude glycerol as a carbon source for 
applications of the secondary metabolite as a food preservative. 
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CHAPTER 1. LITERATURE REVIEW 
 
1.1. Streptomycetes 
Streptomycetes are gram positive, rod shaped bacteria which form the largest genus in 
the phylum Actinobacteria (Hodgson, 2000). These bacteria are soil saprophytes; have 
large genomes of ~ 8-10 MB and a high G-C content of >70%. Streptomycetes genomes 
consist of large linear chromosomes and uniquely, mainly linear plasmids, although 
circular ones are also found (Hopwood, 2006). 
The morphology of Streptomyces cells are displayed by chains of extensively branched 
mycelia which share a similarity to filamentous fungi. The growth cycle of these bacteria is 
very complex and begins with filamentous vegetative growth and the formation of aerial 
hyphae followed by differentiation of the hyphae into spore chains (Kieser et al., 2000) 
(Figure 1.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Another distinctive quality of Streptomycetes is their ability to synthesize many secondary 
metabolites/natural products, (Davies and Ryan, 2012) near the end of the 
microorganisms’ growth phase (Hopwood, 2006). 
 
Figure 1.1. The lifecycle of Streptomycetes bacteria. A vegetative mycelium 
germinates from a single spore followed by aerial growth with the production of aerial 
hyphae. These undergo sporulation to form spore chains (Reproduced from Paradkar et 
al., 2003). 
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1.1.1. Streptomycetes secondary metabolites 
Among actinomycetes, around 2400 unique compounds are produced by Streptomyces 
species and are therefore known as the industrial source of secondary metabolites 
(Berdy, 2005; Lucas et al., 2012). Each secondary metabolite is normally encoded by 
large 20-30 biosynthetic gene clusters (Thompson et al., 2002; Ikeda et al., 2003; Oliynyk 
et al., 2007) which can reach up to 100 Kb in size (August et al., 1998; Donadio et al., 
2002).  These gene clusters are the main targets for the improvement of secondary 
metabolite production during engineering experiments.  
The main types of secondary metabolites produced by Streptomyces are antibiotics, 
antifungal agents (Lee et al., 2009), food preservatives (Hiraki et al., 2003), anthelmintic 
and antitumour agents (Lee et al., 2009). Each of these categories of metabolites are 
important in industry and requires large scale production to cater for the growing market.  
For the purpose of this research, one particular Streptomyces species, Streptomyces 
albulus has been selected for study in terms of its secondary metabolite production.  
 
1.1.2. Streptomyces albulus 
S. albulus is an aerobic, soil bacterium which grows in the same characteristic way as 
other Streptomycetes described in section 1.1. S. albulus grows fairly slowly at 
temperatures between 25-30°C and a neutral pH of 6.8-7.0 (Shepard et al., 2010) (Figure 
1.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
There is currently limited information on S. albulus and only recently, the genome was 
sequenced using the MiSeq platform from Illumina. The genome is 9.43 Mb in size and 
has a very high G-C content of 72.2%, which follows suit of other Streptomycetes 
genomes (Dodd et al., 2013).  
Figure 1.2. The growth of S. albulus on LB agar after different days of growth.  (a) 3 
days post spreading. (b) 5 days post spreading, showing a lawn of hyphae on the plate. 
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S. albulus has been the subject of studies for several years due to its ability to produce a 
very important polyamino acid (Shima and Sakai, 1977).  
 
1.2. Polyamino acids 
Microorganisms have the ability to produce a wide range of biopolymers which are the 
most abundant molecules in living matter. There are several types of biopolymers which 
include polynucleotides, polysaccharides, polyesters, polyketides and polyamides 
(Hamano, 2011). Polyamides (proteins) are a class of biodegradable polymers which 
consist of repeating units linked by amide bonds. There are two main types of polyamides: 
homopolyamide which consist of one type of monomer and copolyamides (or proteins), 
which are made up of different kinds types of monomers. Subsets of polyamides are 
known as polyamino acids and these are different to regular proteins due to the way they 
are synthesized (Oppermann-Sanio and Steinbüchel, 2002). There are three naturally 
occuring polyamino acids which are polyglutamic acid (PGA), polylysine (Hamano, 2011), 
and cyanophycin (Oppermann-Sanio and Steinbüchel, 2002) (Figure 1.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
This project focused on the polyamino acid, polylysine and therefore PGA and 
cyanophycin will not be discussed further.  
 
1.3. Polylysine 
Lysine, a positively charged proteogenic amino acid, is not produced by the human 
metabolism but is essential for growth and also plays a vital role in the production of 
carnitine, which is responsible for converting fatty acids into energy and lowering 
cholesterol. Lysine also helps the body absorb calcium, and therefore the formation of 
A B C 
Figure 1.3. The structures of three naturally occuring polyamino acids. (a) 
polyglutamic, acid (b) polylysine and (c) cyanophycin. The figure shows the monomeric 
structure which can be repeated several times; represented by the n to form the polyamino 
acid.  (Reproduced from Oppermann-Sanio and Steinbüchel, 2002).  
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collagen, a substance important for bones. The consumption of lysine occurs through the 
intake of foods (Tomé and Bos, 2007). 
There are two main types of homopolyamides of lysine, poly-α-lysine (α-PL) (Sela and 
Katchalski, 1959) and poly-ε-lysine (ε-PL) (Shima and Sakai, 1977). The former is only 
chemically synthesized and has been investigated in several human drug delivery 
systems, however poly-α-amino acids are toxic and therefore its applications are limited 
(Sela and Katchalski, 1959). ε-PL on the other hand is naturally produced and is therefore 
of interest in many studies for its possible applications.  
 
1.3.1. ε-PL 
ε-PL was first discovered in 1977 by Shima and Sakai during an experiment involving 
screening for Dragendorrf’s positive substances produced by S. albulus ssp 
lysinopolymerus 346 isolated from the soil. Further studies were performed to verify that 
the substance consisted of only the L isomer of the amino acid thus, when ε-PL is referred 
to, it is the L isomer (Shima and Sakai, 1981). ε-PL is a naturally occuring secondary 
metabolite which is a cationic, homopolymeric compound consisting of 25-35 lysine 
monomer repeats. There is a peptide bond between the ε-amino and the α- carboxyl 
groups (Figure 1.4).  
 
 
 
 
 
1.3.2. Occurrence of ε-PL in other microorganisms 
Although S. albulus was the first microorganism in which ε-PL was discovered, recently 
other ε-PL producing strains were discovered.  One study involved the use of a method of 
detecting basic polymers (such as polylysine) which may interact with a charged dye 
embedded in an agar plate  This study by Nishikawa and Ogawa, 2002, involved the 
isolation of more than 10 ε-PL producing species from 300 soil samples. These organisms 
came from the genera Streptomyces and Kitasatospora mainly. Another study by Hirohara 
et al., 2007 made use of a two stage culture method for screening ε-PL producers. Using 
this method, a further 10 strains and their ε-PLs were studied. It was found that the ε-PLs 
Figure 1.4. A schematic representation of the structure ε-PL. Polylysine is made up of 
25-35 lysine monomer repeats and there is a peptide bond between the ε-amino and the α- 
carboxyl groups  (Reproduced from Chen et al., 2013).  
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showed variable lengths and were all from the genus Streptomyces and the longest chain 
consisted of 36 L-lysine residues which is the longest found to date.  
 
1.3.3. Conformation of ε-PL 
Several studies have investigated the molecular structure and the conformation of ε-PL 
produced by a strain of S. albulus in aqueous solution. These experiments employed 
nuclear magnetic resonance (NMR), infrared (IR) and circular dichroism (CD) 
spectroscopy (Kushwaha and Mathur, 1980; Lee et al., 1991, 1995; Fukushi et al., 1993).  
The results from all the experiments follow the consensus that ε-PL is in a β sheet 
conformation.  
 
1.3.4. Production of ε-PL 
Kawai et al., 2003 first reported that ε-PL may be produced by a non-ribosomal peptide 
synthetase (NRPS). NRPSs are multifunctional enzymes which have multiple semi-
autonomous domains that have the ability to synthesize numerous secondary metabolites 
(Mootz et al., 2002; Schwarzer et al., 2003; Strieker et al., 2010). These enzymes function 
using a thio-templated mechanism to activate, tether and modify amino-acid monomers 
creating the polypeptide chain. The sequence and length of the peptide product is 
determined by the order and number of modules of an NRPS.  
In order to confirm or discard the above hypothesis, Yamanaka et al., (2008) attempted 
identifying an ε-PL synthetase (Pls). To do this a protein extraction method was used by 
growing cells of S. albulus NBRC14147, sonicating and centrifuging them to obtain a cell 
free extract. The presumptive Pls was purified by column chromatography and the 
molecular mass was estimated by gel filtration chromatography and sodium dodecyl 
sulphate- poly-acrylamide gel electrophoresis (SDS-PAGE). The estimated molecular 
mass was shown to be 270 kDa and 130 kDa for each method respectively, thus, 
suggesting that Pls is a homodimer.   
To further prove that Pls is in fact responsible for ε-PL production, the purified enzyme 
was incubated with L-lysine and adenosine triphosphate (ATP).  A polydisperse group of 
enzyme dependent polymer products were detected, supporting the fact that this enzyme 
is responsible for ε-PL production (Yamanaka et al., 2008). 
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Catalytic mechanism of Pls 
From the studies performed on Pls it was discovered that the enzyme does not have a 
classical structure of a traditional NRPS. However, the enzyme showed the presence of a 
typical adenylation domain (A-domain) and thiolation domain (T-domain) at the N-terminal 
region. These domains are responsible for the activation of the amino acid substrate and 
the formation of an intermediate acylthioester as well as adenosine monophosphate 
(AMP) release respectively (Mootz et al., 2002; Schwarzer et al., 2003). Pls does not 
possess domains with sequence similarity to the traditional condensation domains (C-
domains) which are vital in peptide bond formation.  Finally, there is no thioesterase 
domain (TE-domain), which functions to release the final secondary metabolite. 
Physiochemical analysis suggested the existence of six transmembrane domains (TM-
domains) and three soluble C domains (Yamanaka et al., 2008; Kito et al., 2012)  
(Figure 1.5).  
 
 
 
 
 
 
 
1.3.5. Degradation of ε-PL 
Apart from Pls, an ε-PL degrading enzyme (Pld) has been identified, purified and 
characterized (Kito et al., 2002). This enzyme functions at a pH of 7.0 and degrades ε- PL 
back to L-lysine through a process of depolymerisation (Kahar et al., 2001). The pld gene 
has been reported to play a role in self resistance against ε-PL (Kito et al., 2002; Hamano 
et al., 2006). 
 
1.3.6. Measurement and purification of ε-PL 
Several methods have been developed to measure the concentration of ε-PL, which are 
either colorimetric or enzymatic. Itzhaki, (1972) discovered a colorimetric method which 
uses the fact that ε-PL can interact with an anionic dye, methyl orange. This method 
works on estimating unbound ε-PL residues using spectrophotometry. The disadvantage 
Figure 1.5. Domain architecture of the Pls protein. The A domain, T domain, six TM 
domains and three tandem domains (C1 domain, C2 domain and C3 domain) are shown 
schematically. The numbers on Pls are the amino acid residue numbers (Yamanaka et al., 
2008). 
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of using this technique is that ε-PL of only relatively high concentrations (>10 μg/ml) can 
be detected.  Shen et al., (1984) then discovered that the same colorimetric method can 
be used with trypan blue. The absorbance of unbound dye in the supernatant is inversely 
proportional to the concentration of this polyamino acid. The advantage of using trypan 
blue is that ε-PL concentrations of between 1 μg/ml and 10 μg/ml can be detected. This is 
about 10-fold lower than that of the methyl orange precipitation method. Once a sufficient 
amount of ε-PL has been measured, for application purposes, it needs to be purified.  
 
ε-PL can be purified by ion exchange chromatography from the culture broth due to the 
fact that it is a cationic polymer at a neutral pH (Shima and Sakai, 1977).  
 
1.3.7. Function of ε-PL for the bacteria 
Due to the fact that the Streptomyces are found in the soil, there are many other 
competing bacteria in their surroundings. In order to minimize the competition for 
themselves they produce ε-PL to serve as an antimicrobial agent in their habitat. This 
secondary metabolite offers a potentially significant selective advantage to the bacteria 
(Yoon and Nodwell, 2014).  
 
1.3.8. Applications of ε-PL 
ε-PL has been of interest in the past few years for a wide variety of industrial applications 
in food, medicine, environment and electronics. ε-PL can be utilized in many different 
ways such as a food preservative , emulsifying agent, dietary agent, biodegradable fibres, 
highly water absorbable hydrogels, drug carriers, anticancer agent enhancer and bio- chip 
coatings. These applications are summarized in Table 1.1. 
 
 
Field of application Application examples                    
Food Industry 
Natural food preservative (Shima and Sakai, 1983) 
Dietary agent (Kido et al., 2003) 
Medical Industry 
Drug delivery carrier (Shen and Ryser, 1979,  Shen and 
Ryser ,1981; Ryser and Shen, 1978) 
Lipopolysaccharides (LPS)-Endotoxin removal (Sakata 
et al., 2002) 
Non-viral gene delivery vectors (Choi et al., 2000) 
Other applications 
Hydrogels (Yoshida and Nagasava, 2003) 
Bioelectronics (Ostuni et al., 1999) 
Table 1.1. The applications of ε-PL in various fields. 
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The function that is of interest in this study is the use of ε-PL as a natural and safe food 
preservative due to its antimicrobial properties.  
 
Antimicrobial activity of ε-PL 
ε-PL is unique as an antimicrobial agent as it has been shown to have activity against 
both bacteria and fungi, and even against bacteriophages. In addition, ε-PL is water 
soluble, biodegradable, edible and nontoxic towards humans and the environment 
(Hamano et al., 2011).  The process behind the antimicrobial activity is adsorption to the 
cell surface of bacteria and fungi. Adsorption involves the binding of atoms or ions from a 
gas, liquid or dissolved solid on cell surface. This results in the attachment to the outer 
membrane resulting in the disruption of the cytoplasm and eventually leads to cell death 
(Shima et al., 1984). 
The chain length diversity of ε-PL is directly related to its antimicrobial activity. Shima et 
al., (1984) found that ε-PL with more than nine L-lysine residues has a high antimicrobial 
activity and therefore inhibits microbial growth. On the contrary, an ε-PL octamer showed 
negligible antimicrobial activity. 
Due to relatively wide antimicrobial spectrum, it has been used as a preservative in Japan, 
China and the United States. It is considered to be a safe addition in several staple foods 
such as fish sushi, soups, cooked vegetables, noodles and boiled rice. Levels of up to  
20 000 to 50 000 ppm of ε-PL can be added to the food with no notable adverse effects, 
according to toxicology studies performed in rats (Hiraki et al., 2003). Furthermore, lysine 
which is not naturally produced by the body is essential for growth and plays a vital role in 
the production of carnitine which is responsible for converting fatty acids into energy and 
lowering cholesterol. Lysine also helps the body absorb calcium, and therefore the 
formation of collagen, a substance important for bones (Singh et al., 2005).  
Seeing that ε-PL has such huge economic potential, there has been recent interest in a 
by-product, crude glycerol during the production of a biodiesel, a biofuel, to lower the cost 
of ε-PL production.  
 
Applications of ε-PL in an African context 
The L-lysine residues found in ε-PL have application as feed additives in livestock.  Only 
one producer of L-lysine was known in Africa and obtained the residues from molasses 
which is ten times as expensive as crude glycerol. The use of crude glycerol for L-lysine 
may be economically valuable for farmers and biodiesel producers. South Africa 
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consumes about 9000 tonnes of L-lysine annually, which is all imported as the L-lysine 
plant in Richards Bay was converted to a yeast production plant. Thus, there is a space to 
produce ε-PL more economically and in larger quantities (Zhou, 2010).  
 
1.4. Biofuels 
At present, fossil fuels are both costly and responsible for large amounts of pollution in the 
form of carbon emissions. Furthermore, their reserves are depleting due to over 
exploitation (Campbell and Laherrère, 1998). For these reasons the focus has moved to 
alternative bio-based fuel sources (Hill et al., 2006).  
Biodiesel is an alternative fuel source which is derived from triglyceride oils and can 
substitute fossil diesel. Biodiesel is both non-toxic and biodegradable which has led to its 
commercialisation within several countries (Peterson and Reece, 1994). The production of 
biodiesel through the process of transesterfication generates approximately 10% of low-
grade crude glycerol, which is considered a waste product (Figure 1.6) (Dasari, 2007). 
Currently crude glycerol’s supply is greater than its demand due to cost implications for its 
disposal and purification. To bypass these costs, crude glycerol could be utilized in 
different applications such as chemical requirements for bacterial growth (Johnson and 
Taconi, 2007). 
 
 
 
 
 
 
 
 
1.5. Crude glycerol 
Glycerol, also known as glycerine, is a colourless, odourless liquid. Glycerol is nontoxic to 
human health and the environment and is therefore used in industrial cosmetic, food, 
pharmaceutical and domestic products.  Glycerol can exist in two forms both crude and 
pure, whereby the former has impurities such as potassium salts and is about 70-80% 
pure (Ayoub and Abdullah, 2012).  
Figure 1.6. The process of transesterfication of triglyceride oil for production of 
biodiesel and glycerol. Biodiesel is produced using a triglyceride and an alcohol (such 
as methanol) in the presence of a catalyst to form glycerol (Reproduced from Chisti, 
2007). 
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Very few bacteria are able to make use of crude glycerol as a carbon source (Wilke and 
Vorlop, 2004). In a previous study in our laboratory, crude glycerol from six South African 
biodiesel producers was tested as a carbon source supplement for S. albulus. From this 
intial investigation it can be seen that there is a possibility for an effective use of crude 
glycerol as S. albulus is able to utilize crude glycerol although this has not been optimised.   
One of the main advantages of using crude glycerol is the excess of it due to the increase 
in biodiesel production. This has reduced its price, thus, making it affordable in 
biotechnological applications. The current price of crude glycerol is low, $0.04–0.11/kg 
and biodiesel producers are storing it until alternative uses are identified (Bohon et al, 
2011). From this it can be said that glycerol is a sustainable biological feedstock for the 
production of certain products due to its availability and economic viability. The challenges 
of using crude glycerol are the impurities associated which could potential lead to slow 
bacterial growth rate and hence, secondary metabolite production (Çelik et al., 2008). .  
 
1.6. Economic feasibility of ε-PL production 
In order to determine whether there is a market available ε-PL production in South Africa, 
several figures around its production and cost need to be taken into account. The average 
cost of ε-PL is $ 5000/kg and fermentations on average can produce 40 g/L using a 5 L jar 
fermenter (Kahar et al., 2001). Running the fermenter will require man power costing 
approximately $ 220 a day per individual and thus 3 individuals would cost $ 660 per day. 
There are currently many different preservatives available on the market and the cost 
price of one such preservative, sodium benzoate is US $ 1,340 - 1,355 / 1000 kg (Food 
preservatives, 2012). Although these preservatives appear more cost efficient, much 
larger quantities are required for effective use as compared to ε-PL. 
Due to the high cost of ε-PL to optimise, ε-PL production through genetic or metabolic 
engineering in order to lower the price. 
 
1.7. Genetic Engineering 
A variety of high-value secondary metabolites are produced by microbial fermentation 
(Demain, 2006). In many cases, the production of these products has not been optimised 
to an industrial scale and the enhancement of metabolic reactions to increase the yield is 
the focus of much prior, on-going and future research (Baltz, 2011). Throughout the years, 
a wide range of engineering techniques have been employed for these purposes.  
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Previously, genetic engineering involved random mutagenesis without the targeting of a 
specific gene. More recently genetic engineering has moved to target specific genes. 
(Nielsen, 1998; Adrio and Demain, 2006). This is attributed to the recent advances in the 
development of modern technologies such as second and third generation sequencing, 
genomics, proteomics, metabolomics, transcription profiling and transcriptomics has 
allowed for more efficient ways to engineer microorganisms for secondary metabolite 
production (Bro and Nielsen, 2004). 
Genetic engineering involves several steps: The first being to choose clinically or 
industrially relevant secondary metabolites that are amenable to engineering. This 
amenability is usually attributed to the host organism. The general steps in genetic 
engineering involve: (a) cloning and sequencing the biosynthetic genes responsible for the 
production of the secondary metabolite; (b) using efficient tools to engineer the 
biosynthetic pathway by random mutagenesis, extra chromosomal or whole genome 
engineering; (c) choosing or developing suitable gene transfer methods, expression hosts 
and methods to stably maintain and express the engineered biosynthetic gene(s) (Baltz, 
2006). 
 
1.7.1. Cloning and Engineering the biosynthetic gene(s) 
In order to genetically engineer a gene, it needs to be produced in large amounts. This is 
usually performed by removing the gene from its natural location and ligating it onto a 
plasmid and cloning it into Escherichia coli. Through the growth of E. coli, the gene(s) will 
be expressed in large quantities and may be used for subsequent genetic engineering 
steps. Each genetic engineering experiment uses a different E. coli strain and plasmid for 
cloning and therefore these must be selected based on the experiment specifications 
(Baltz, 2006).  
 
1.7.2. Random Mutagenesis 
Random mutagenesis involves the use of radiation or chemical compounds to randomly 
produce changes in the DNA. This is followed by screening of the mutant strains for the 
single best performer for the product in question. This technique is used less frequently 
because it does not give information on genes and molecular mechanisms during the 
improvement and it is likely that some mutations may be detrimental or neutral in terms of 
production (Alduina and Gallo, 2012).  
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1.7.3. Extra chromosomal engineering 
Extra chromosomal engineering involves the use of plasmids, bacterial artificial 
chromosomes (BACs) or cosmids which are inserted as a separate entity into a 
microorganism, containing the gene(s) required for the production of the target product, 
which is then expressed. Certain biosynthetic gene clusters are extremely large and in 
order to engineer them, artificial chromosomes that can be stably maintained in 
Streptomyces have been constructed.  These vectors can allow for the mobility of genetic 
information from an original producer to a more genetically suitable and amenable host for 
the particular gene expression (Alduina and Gallo, 2012).  
Plasmids are most commonly used for engineering strategies but are limited to being able 
to hold one or two genes. If the cloning of entire gene clusters is required, cosmids should 
be considered (Alduina and Gallo, 2012).  
 
Cosmids may be used for gene clusters of up to 45kb in size and show high 
transformation efficiency. The cloning of biosynthetic gene clusters in Streptomyces has 
shown to be successful in several cases. These include the transfer of several antibiotic 
gene clusters such as blasticidin of S.  griseochromogenes (Cone et al., 2003); 
validamycin from S.  hygroscopicus (Singh et al., 2006) and lincomycin from S.  
lincolnensis (Koberská et al., 2008). The limitation of this strategy is that many 
biosynthetic gene clusters for natural products are larger than 45kb and therefore cosmid 
vectors are not suitable. In order to overcome this, bacterial artificial chromosomes 
(BACs) may be employed (Gust et al., 2004). 
 
BACs may be used for the insertion of gene clusters which are larger than 100kb. These 
can be carried in E. coli but are not suitable for heterologous expression due to the G-C 
rich nature of Streptomyces genomes. Vectors have been designed that can be shuttled 
between E. coli and Streptomyces. The E. coli strain can be used for library construction 
and manipulation while the Streptomyces strain will be for gene expression and secondary 
metabolite production. Gene clusters can be introduced within a few days and then can be 
integrated into the Streptomyces chromosome for further analysis (Gust et al., 2004).  To 
date two BACs have been constructed to host gene clusters for Streptomyces 
engineering: pSTREPTOBAC V (Miao et al., 2005) and pSBAC (Liu et al., 2009). These 
BACs have been used for the cloning of antibiotics daptomycin biosynthetic gene cluster 
in S.  roseosporus. Both these vectors are able to replicative in E. coli and integrate into 
Streptomyces. Recombinant clones can then be selected by antibiotic resistant markers 
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found on the vectors. Both pSTREPTOBAC V and pSBAC contain an apramycin 
resistance selectable marker for recombinant clone selection (Alduina and Gallo, 2012).  
Many studies avoid the use of extra chromosomal engineering as a method of 
manipulating the Streptomyces genome as more advanced and rapid methods (discussed 
in section 1.9) have been created. The reason for this is to avoid issues such as vector 
replication, stability, incompatibility and copy number variance (Heil et al., 2012). 
However, if an entire gene cluster is required to be expressed in a heterologous host this 
method cannot be avoided. 
 
1.7.4. Whole genome engineering by PCR based methods 
Whole genome engineering involves the editing of the genome of the microorganism by 
the insertion or deletion of specific genes or promoters. The latter methods require 
knowledge of the gene sequence and function and the type of techniques which may be 
used for genetic engineering. Previously, genetic engineering techniques were limited by 
restriction enzymes and availability of restriction sites which can obstruct the introduction 
of DNA into Streptomyces. Another limitation included the use of self-replicating plasmid 
vectors which can inhibit secondary metabolite production. Lastly, recombinant strains 
containing heterologous DNA may have effects on the regulation of the host genome. 
These hurdles were overcome by the use of intergeneric conjugation to avoid host 
restriction, and integration of cloned DNA into neutral genomic sites which prevents 
product inhibition by self-replicating plasmids, and has enabled construction of 
recombinant strains lacking heterologous DNA sequences (Baltz and Hosted, 1996). 
Until recently, techniques for the introduction of defined changes into Streptomyces 
chromosomes were very time‐consuming. In particular, manipulation of large DNA 
fragments has been challenging due to the absence of suitable restriction sites for 
restriction‐ and ligation‐based techniques. The homologous recombination approach 
(Gust et al., 2003) and phage integration systems (Baltz, 2012) have greatly facilitated 
targeted genetic modifications of complex biosynthetic pathways in Streptomyces by 
eliminating many of the time‐consuming and labour‐intensive steps.  
Although genetic engineering has been successful in improving secondary metabolite 
production the emergence of a new field may show further improvement. Metabolic 
engineering considers whole cellular systems and any genetic manipulations would 
change the efficiency of the overall bioprocess, thus distinguishing it from simple genetic 
engineering (Kern et al., 2007).  
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1.8. Metabolic Engineering 
Metabolic engineering has been described as the “improvement of cellular activities by the 
manipulation of enzymatic, transport and regulatory functions of the cell with use of 
recombinant DNA technology” (Bailey, 1991). Metabolic engineering allows for defined 
and rationalised changes to be made to the organism to render a particular improvement 
(Kern et al., 2007). 
There may be several different motives for the metabolic engineering of microorganisms 
which include (Kern et al., 2007): 1. Improvement of yield and productivity of a 
commercially viable product. 2. Extension of the substrate range of a product.  3. Removal 
or reduction of by-product formation 4. Introduction of innovative pathways for product 
production.  
Metabolic engineering is a multistep process.  Firstly, a target product and its wild type 
host are selected followed by computational analysis of metabolic pathways in its 
production. A genetic modification is proposed, based on analysis of metabolic pathways 
relating to the product of interest. After genetic modification, the recombinant (engineered) 
strain is analysed and the results are then used to identify the next target for genetic 
manipulation, if necessary. Lastly, fermentation studies and other downstream processes 
are performed for industrial scale production of the target product (Kern et al., 2007). 
Metabolic engineering can be achieved through several different approaches which 
improve the efficiency of the secondary metabolite production pathway. These include: 
precursor engineering, engineering structural genes, engineering regulatory networks and 
genome shuffling. The necessity for metabolic engineering stems from the complex 
pathways used to synthesize secondary metabolites as opposed to single isolated genes. 
Due to this in depth analysis of the pathways are required followed by the targeting of 
possibly more than one gene in the pathway (Olano et al., 2008).  
 
1.8.1. Precursor Flux Engineering 
Precursors for secondary metabolite production are vital and are often the produced 
through the catabolism of carbon compounds during primary metabolism. This means 
precursors are found at the intersection of primary and secondary metabolism. In order to 
increase the production of secondary metabolites, the precursor should be readily 
available and in certain instances this is not the case. The engineering approach is 
therefore to genetically engineer certain enzymes in order to increase the availability of 
certain precursors in different pathways (Olano et al., 2008).  An example of precursor 
engineering involved actinorhodin, a polyketides antibiotic produced by S. coelicolor, is 
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another example where increased precursor availability leads to enhancement of product 
production. Ryu et al., (2006) attempted overexpressing by adding an additional copy on a 
plasmid. accA2, accB and ace genes which code for the different subunits of the enzyme 
acetyl-CoA carboxylase (ACC). These genes are precursors for actinorhodin production.  
The results showed an enhancement of carbon flux to malonyl-CoA, which is also a 
precursor enzyme of actinorhodin resulting in a 6-fold increase in the production of the 
product.  
 
1.8.2. Engineering structural genes 
Structural genes found in the metabolic pathways responsible for the production of the 
secondary metabolites are usually attractive targets for metabolic engineering. In these 
cases, the gene dose may be increased; the gene may be inactivated, deleted or modified 
(Olano et al., 2008).  
 
Gene dose increase 
Increasing the dose of a particular gene would theoretically correspond to an increase of 
the target protein and thus, increase the production of secondary metabolites. Integration 
of the clavaminate synthase gene, cas2 into the chromosome of S. clavuligerus, resulted 
in up to five-fold increase in clavulanic acid production. This was done using recombinant 
plasmids designed in the study. Plasmids were constructed for both overexpression and 
different plasmids for chromosomal integration and transformed into S. clavuligerus (Hung 
et al., 2007). 
 
Inactivation or deletion of genes 
Inactivation or deletion of genes can improve metabolite production by removing genes 
coding for activities that transform the metabolite into a different one. In addition it can 
also involve the removal of genes whose products inhibit or degrade the target product 
(Olano et al., 2008).  Inactivation of the nysF gene by the insertion of a kanamycin 
resistance marker into its coding region, and by in-frame deletion improves nystatin 
production by 60% which suggests a negative role of the gene in nystatin biosynthesis 
(Zelyas et al., 2009).  
 
1.8.3. Engineering regulatory networks 
Genes for the biosynthesis of secondary metabolism pathways are commonly grouped 
together in clusters on the chromosome including their pathway-specific regulatory genes. 
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Pathway-specific regulators can have either positive (activators) or negative (repressors) 
effects on the expression of gene cluster elements. There are clusters containing a 
different number of pathway-specific positive regulatory genes. The best-known example 
is S. coelicolor that produces several antibiotics (actinorhodin, calcium-dependent 
antibiotic, undecylprodigiosin and methylenomycin) and where the onset of their 
biosynthesis is controlled by specific regulators (actII-orf4, cdaR, redD and redZ), while 
there are several pleiotropic genes (i.e. afs, abs and bld) affecting antibiotic production 
and, in addition, the morphological development of the bacteria (Huang et al., 2005). 
Taking into account all previous observations it seems obvious that deregulation of the 
expression of secondary metabolite pathways, by overexpression of pathway-specific 
positive regulators or by inactivation of pathway repressors, is the most intuitive approach 
for the improvement of their production. 
 
1.8.4. Up-regulation 
The up-regulation of genes is usually controlled by regulatory sequences on the DNA. In 
Streptomyces, there are such regulators that activate the transcription of biosynthetic 
genes. These are known as SARP (Streptomyces antibiotic regulatory proteins). One 
such SARP, AfsR-p from S.  peucetius have been shown to enhance doxorubicin 
biosynthesis (Parajuli et al., 2005). In addition, overexpression of AfsR-p in S. lividans, S. 
clavuligerus, S. griseus and S. venezuelae on a plasmid leads to overproduction of 
actinorhodin, clavulanic acid, streptomycin and pikromycin, respectively (Parajuli et al., 
2005 ; Maharjan et al., 2008). 
 
1.8.5. Down-regulation 
The down regulation of genes is also controlled by regulatory sequences in DNA, 
however, in this case these would be pathway-specific repressors. The inactivation of 
these can lead to overproduction of secondary metabolites. This is the case of 
chromomycin whose production is increased when a pathway- specific transcriptional 
repressor cmmRII is inactivated in S. griseus ssp. griseus using a plasmid (Menéndez et 
al., 2007). 
A well-known pleiotropic repressor system related with phosphate regulation of secondary 
metabolite production is the two-component phoR–phoP system. Disruption of phoR or 
simultaneous deletion of both phoR and phoP has been recently shown to increase 
pimaricin production in S. nataliensis. Deletion of the same system in S. lividans was 
reported to boost actinorhodin and undecylprodigiosin production, 5- and 12-fold increase, 
respectively (Sola-Landa et al., 2003). 
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1.9. Genetic/metabolic engineering for ε-PL improvement in S. albulus 
There have been several attempts to improve ε-PL production in S. albulus either through 
attempting to improve the fermentation culture conditions or by using genetic and/or 
metabolic engineering.  
  
1.9.1. Improvement of ε-PL production using fermentation culture conditions 
The first way to optimize the production of a secondary metabolite such as ε-PL would 
require the optimization of the growth and fermentation conditions of S. albulus. There 
have been various reports of such nature regarding the enhancement of ε-PL production. 
The first attempt was by Shima et al., 1983 which involved the optimization of ε-PL 
production using a two-step cultivation method. This method involved the growth of S. 
albulus in two different mineral media which improved the production of ε-PL to 4-5 g/L 
after 8 days (as compared to 0.2 and 0.5 g/L originally produced) (Shima and Sakai, 1977; 
Shima and Sakai, 1981).  
 
Hiraki et al., (1998) attempted to increase ε-PL by isolating a mutant of S. albulus (strain 
346) by the use of nitrosoguanidine which is a mutagenic agent. This produced a 2-
aminoethyl-L-cysteine (AEC) and glycine resistant mutant that was capable of producing 
four times greater amounts of ε-PL of 1.2 g/L after 96 hours in M3G medium.  
 
Another attempt which aimed at pH control of the culture broth to maximize ε-PL 
production was attempted using glucose as a carbon source (Kahar et al., 2001). The 
results produced employ a two phase system of pH control in a continuous culture. In the 
first phase (day 1 and 2), the pH>5 in order to allow the growth of the bacteria optimally. In 
the second phase (day 3-8), the pH is maintained between 4.0 and 4.2 in order to allow 
for ε-PL production. Such maintenance can allow for ε-PL production as high as 48.3 g/L. 
It is vitally important to maintain a glucose concentration at 10 g/L because if glucose is 
consumed completely, its depletion causes a rapid increase in pH due to ammonia 
accumulation. 
 
Chen et al., (2011) used Streptomyces sp. M-Z18 to observe the production of ε-PL using 
glycerol as a carbon source. The media used was improved in order to optimize ε-PL 
production while the pH was initially 6.8 but was not controlled further in the experiment at 
a temperature of 30°C. The results showed that 2.27 ± 0.15 g/L of ε-PL was produced 
after 96 hours in a batch fermentation culture.  
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Most recently, Shukla and Mishra, 2012 studied optimisation of different parameters for ε-
PL production by changing one factor at a time using the wild type S. albulus strain. 
According to this study, the carbon source which produces the highest amount of ε-PL (88 
hours at 30°C) is a combination of glucose to glycerol (weight ratio 1:1),  produced  
1.2 g/L. In addition, the optimal inorganic and organic nitrogen sources were found to be 
ammonium sulphate and yeast extract respectively.  
 
1.9.2. Improvement of ε-PL production using genetic or metabolic engineering 
Another way to improve the production of ε- PL in S. albulus once growth and 
fermentation conditions have been optimized is the use of metabolic engineering.  
 
In a previous study in this department, there was an attempt to clone the glycerol operon 
which contains three genes (glpD, glpF and glpK) from E. coli. This is because E. coli 
shows very efficient glycerol metabolism due to the presence of these genes and could 
subsequently enhance the glycerol utilization. The study however only showed successful 
cloning of the glpD. In the same study it was shown that there is a limit to the amount of 
carbon utilization as the amount of glycerol increases. In addition it was shown that there 
is a weak negative correlation between the amount of ε-PL produced and carbon 
utilization. This provides the motivation for metabolic engineering of S. albulus to improve 
glycerol utilization.  
 
The L-lysine molecule is utilized to produce ε-PL and is biosynthesized by the aspartate 
pathway. The first two enzymes in the pathway are aspartokinase (Ask) and aspartate 
semialdehyde dehydrogenase (Asd). Ask is responsible for catalysing the phosphorylation 
L-aspartic acid to L-4-phospho aspartic acid. These enzymes are highly regulated and 
different bacteria have different patterns of their regulation. Many of the Ask genes in 
different bacteria are susceptible to feedback inhibitions. S. albulus Ask was found to be 
partially resistant to feedback-inhibition (Hamano et al, 2007).  Hamano et al proceeded to 
create a mutant Ask, rAsk (M68V) whose feedback inhibition regulation was completely 
removed. The results showed that Ask produced a maximum of 15 g/L of ε-PL as opposed 
to 11 g/L in the wild type. This is an example of the concept of biocatalysis which can be 
defined as the use of biological molecules, usually enzymes to catalyse certain reactions 
for the production of natural products (Schmid et al., 2001).  
Most recently, genome shuffling has been used as an engineering technique. Genome 
shuffling involves DNA fragmentation and ligation in order to create possible beneficial 
mutations. Genome shuffling has been described as a new method that can rapidly 
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enhance secondary metabolite production. The most recent example of this technique is 
for production of ε-PL in five Streptomyces species. In this case genome shuffling and 
interspecific hybridization (combining DNA of two species from the same genus), via 
ultraviolet (UV) irradiation allowed for the construction of hybrids which showed 3-fold 
improvements in ε-PL production (Li et al., 2013).  
Lastly, the effects of precursor engineering, whereby external L-lysine on ε-PL production 
was evaluated in Streptomyces sp. M-Z18. In combination with glucose–glycerol co-
fermentation ε-PL production, was shown to be 37.6 g/L, which was 6.2 % greater than 
without added L-lysine (35.14 g/L) (Chen et al., 2013).  
 
1.10. Novel engineering mechanisms in S. albulus 
There have been several fairly novel engineering techniques which have been used for 
genetic changes in different kinds of bacteria. Two examples of such methods include 
group II introns and recombineering. These methods have not been used with S. albulus 
and will therefore be discussed in detail below.  
 
1.10.1. Group II Introns 
Group II introns are a class of introns found in rRNA, tRNA, mRNA of organelles in fungi, 
plants, protists, and mRNA in bacteria (Dai and Zimmerly, 2003). They were first 
discovered in mitochondria and chloroplast genomes of eukaryotes and higher plants 
(Michel et al., 1989).  The first intron to be found in a prokaryote was a group I intron in a 
bacteriophage in 1984 (Chu et al, 1984). Following this, both group I and II introns have 
been found in different types of bacteria. Bacterial group II introns were initially identified 
by PCR screens (Ferat and Michel 1993) and then later by genome sequencing which 
revealed that they are very common in both Gram-negative and Gram-positive bacteria 
(Dai and Zimmerly, 2003). 
Group II introns are catalytic RNAs which have the ability to catalyse their own splicing 
(Reinhold-Hurek and Shub, 1992). In addition they have the ability to function as mobile 
elements. The mobility characteristic of the introns resembles that of non-long-terminal-
repeat (LTR) retrotransposable elements (Curcio and Belfort, 1996) and can be utilized as 
a method of gene disruption via their insertion into a desired DNA target (Karberg et al., 
2001). Their mobility is due to a mechanism called retrohoming. This a process whereby 
group II introns self splice and reverse transcribe due to the presence of their own reverse 
transcriptase (RT) and can subsequently insert into intronless genes. This is mediated by 
ribonucleoprotein complex (RNP).  
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The basic procedure on the use of group II intron for gene knockouts is shown in Figure 
1.7. The procedure begins with the reverse splicing of the intron in the exon junction in the 
target DNA. This is followed by the cleavage of the antisense strand and cDNA synthesis 
using the intron RNA as the template. Lastly, recombination and repair activities complete 
the intron insertion process (Karberg et al., 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The retrohoming mechanism makes group II introns an attractive option for genetic 
engineering. Firstly because it has been shown to be both efficient and specific and 
retrohoming frequencies can approach 100%. Lastly the introns are not dependent on 
host factors and are thus applicable to a wide range of bacteria (Targetron® Gene 
Knockout System user guide, 2013).  
 
Structure of group II introns 
Group II introns are made up of 6 domains. Domain I, V, and VI are involved the splicing 
reaction, while domain II and III are involved in stabilization. Doman IV is involved in 
folding or catalytic activity. Domain I is the largest domain, in which the exon-binding 
Figure 1.7. The basic mechanism of a gene knockout using group II introns. (a) The 
target DNA and intron RNA (containing the mobility and catalytic mechanism of the RT) are 
combined, followed by reverse splicing of the target DNA. (b) Cleavage of the antisense 
strand. (c) cDNA synthesis using the intron RNA as the template. (d) Repair of final 
disrupted gene. (Adapted from Karberg et al., 2001).  
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sequences sites (EBS)1 and EBS2 (see section 3.2.3.1) bind specifically to the 
sequences of intron-binding sites (IBS) 1 and IBS 2. Domain V is an essential catalytic 
component of the active ribozyme, and this domain can induce splicing reaction in special 
conditions (Qin and Pyle, 1998).  
 
TargeTron system 
The TargeTron® gene knockout system (Sigma-Aldrich) uses the group II intron principle 
(Figure 1.8) and provides reagents and protocols for the disruption of bacterial genes.  
Firstly, a computer algorithm is used to identify target sites in a gene of interest.  A 1 kb 
gene can be anticipated to contain 5 to 11 group II intron insertion sites. Secondly, the 
computer algorithm outputs primer sequences, which are used to mutate (re-target) the 
intron by PCR. The mutated 350 bp PCR fragment is ligated into a linearized pACD4K-c 
vector that contains the remaining intron components. The ligation reaction is transformed 
into a host organism followed by expression of the re-targeted intron. Knockouts are then 
selected using a kanamycin marker that is activated upon chromosomal insertion. Lastly, 
gene specific primers are used to confirm insertion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The use of this system has proven successful in a wide variety of bacteria shown in Table 
1.2. 
Figure 1.8. The mechanism of the Targetron gene knockout system (Sigma-Aldrich).  
(a) Selection of DNA target site from TargeTron Design Web site  and primer ordering. (b)  
PCR for re-targeting of intron RNA (350 bp PCR product). (c) Cloning of mutated PCR 
fragment into an appropriate expression vector followed by host transformation and 
expression of RNA-protein complex (RNP). Lastly, the re-targeted RNP finds genomic 
target. RNP inserts RNA, reverse transcribes cDNA. (Reproduced from (TargeTron® Gene 
Knockout System user guide, 2013). 
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Adapted from Rodriguez et al., 2008 
 
There are several advantages of using the TargeTron® Gene Knockout System: Firstly 
the retrotransposon allows for insertion of up to 1.8 kb into the genome (Karberg et al., 
2001). In addition possible sequences which can be used for insertion are found every few 
hundred bases which can allow for a large variety of genes to be disrupted (Perutka et al., 
2004). Furthermore, the system allows for the site specific targeted disruption of genes.  
 
There are also several disadvantages of using TargeTron® whereby intron 
retrotransposition efficiencies can vary depending on the species of bacteria as well as 
the site of targeted disruption (Perutka et al., 2004). Moreover, the system has neither 
been attempted nor optimized in S. albulus and thus could be challenging in practise. 
 
1.10.2. Recombineering 
Recombination-mediated genetic engineering (recombineering) is a method that makes 
use of homologous recombination and was first described in E. coli (Zhang et al., 1998). 
The main basis of recombineering is the introduction of a linear DNA construct which is 
Bacterium Reference 
Escherichia coli 
Karberg et al., 2001; Zhong et al., 2003; Perutka 
et al., 2004;  
Shigella flexneri Karberg et al., 2001 
Lactococcus lactis Frazier et al., 2003 
Clostridium perfringens Chen et al., 2005 
Staphylococcus aureus Yao et al., 2006 
Clostridium acetobutylicum Shao et al., 2007 
Pseudomonas aeruginosa Yao and Lambowitz, 2007 
Agrobacterium tumefaciens Yao and Lambowitz, 2007 
Francisella tularensis Rodriguez et al., 2008 
Proteus mirabilis Pearson and Mobley, 2007 
Azospirillum brasilense Malhotra and Srivastava, 2008 
Table 1.2. List of bacteria which have been genetically engineered by group II 
introns. 
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designed to contain the required mutation as well as small homologous sequences to the 
target DNA (Sawitzke et al., 2011). The recombination is mediated by bacteriophage 
proteins using either a RecET (Zhang et al., 1998) or a λ Red (Datsenko and Wanner, 
2000) system and can be used to knockout genes and create deletions.  Since the λ Red 
system is both newer and a more widely used model, it will be the focus of this literature 
review.  
The λ Red system makes use of three phage proteins: Exo, Beta and Gam (Zhang et al., 
1998). Exo is a monomer (Mr 24 000) and is a double stranded exonuclease (5’3’) which 
functions by digesting linear double stranded DNA (dsDNA), leaving a 3’ single strand 
which acts as substrate for successive recombination. The Beta protein (Mr 28 000) is a 
recombinase which facilitates recombination by hybridizing the single strand to its linear 
strand complement. The Gam protein (Mr 16 000) is vital in inhibiting RecBCD 
exonucleases of E. coli which degrade dsDNA, thus allowing the insertion of the linear 
construct without degrading it (Maresca et al., 2010). 
The basic procedure of the λ Red system involves the PCR amplification of a selectable 
marker. The amplification is performed by long primers (~60 nucleotides (nt)) which have 
the 5´end (39 nt) matching the sequence adjacent to the gene to be inactivated, and a 
3´sequence (19 nt or 20 nt) matching the right or left end of the disruption cassette. There 
is then preparation of competent cells for recombineering, electrotransformation or 
conjugation of the selectable marker into the competent cells and selection and 
confirmation of knockout mutations (Datsenko and Wanner, 2000) (Figure 1.9).  
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The differences between E.coli and Streptomyces recombineering is largely attributed to 
the difference in the genetic systems. The basic recombineering technique has been 
adapted for use in various Streptomyces species. In order to adapt recombineering to 
Streptomyces, a two-step strategy is required. In this case a λ-Red-expressing E. coli 
strain containing the target region (on a cosmid clone) is first targeted with a PCR-product 
to replace the Streptomyces gene of interest within the cosmid. The genetic exchange in 
Streptomyces is then achieved by homologous recombination between the chromosomal 
locus and the recombinant cosmid after transformation with cosmid DNA. The reason for 
this two-step strategy is the inability of the E. coli cloning vector to replicate in the 
Streptomyces (Gust et al., 2004). Moreover, there is a requirement for disruption 
cassettes that can be selected in both E. coli and Streptomyces. These disruption 
cassettes contain antibiotic resistance genes and are most commonly: aac(3)IV coding for 
apramycin resistance; aadA coding for spectinomycin resistance and vph coding for 
viomycin resistance. These disruption cassettes can be amplified from the plasmids 
pIJ773, pIJ778 and pIJ780, respectively (Gust et al., 2003).   
 
Due to the use of a “proxy” cosmid, Streptomyces recombineering is time and labour 
intensity. Recombineering protocol in E. coli may take a maximum of 7 days (Sawitzke et 
al., 2011), while in Streptomyces on average it may take up to 3 weeks if the protocol has 
been optimised (Gust et al., 2004).  
Figure 1.9. A crude representation of the basic principle of recombineering. The 
target gene to be knocked out is Gene B which is replaced by a selectable marker.  
Colonies which have lost their target gene can be selected using the selectable marker 
(reproduced from Sawitzke et al., 2011). 
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Nevertheless, an example of a successful recombineering technique for S. coelicolor has 
been described.  The system makes use of several well characterized plasmids which 
contain the three phage recombineering proteins. Examples of such plasmids are pIJ790, 
pKD20 and pKD46. This method was utilized to create over 100 gene disruptions in S. 
coelicolor (Gust et al., 2003) 
 
The λ Red system has also been used to make gene disruptions in other Streptomyces.  
Several examples include the genetic engineering of novobiocin derivatives in S. 
coelicolor (Eustaquio et al., 2004), daptomycin derivatives in S.  roseosporus (Nguyen et 
al., 2006) and bleomycin gene cluster in S. verticillus (Galm et al., 2008). These 
experiments have showed the success of λ Red system by the increase in the production 
of the respective products.  
 
There are several advantages of using recombineering as a gene disruption technique. 
Firstly, it is not limited to areas where there are restriction sites as would be with the use 
of restriction and ligation techniques. Secondly, the constructs are designed to the base 
pair and are therefore very specific to the target region. Thirdly, it can be used to create 
complete gene knockouts, point mutations, deletions, duplications and inversions thereby 
making it a versatile technique (Datsenko and Wanner, 2000). 
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1.11. AIMS AND OBJECTIVES 
Through various work performed both abroad and in our research laboratory it can be 
seen that the growth of S. albulus is slow and the production of ε-PL is not optimal. For 
these reasons, metabolic engineering of the ε-PL production pathway may allow for the 
improvement of this secondary metabolite which would lead to commercialisation. 
Therefore the broad objective of the study was to determine wild type S. albulus 
parameters and develop tools which can be used to genetically and/or metabolically 
engineer S. albulus for the improvement of ε-PL production. These tools would then be 
used in our laboratory to perform gene knock-outs or knock-ins. 
The specific aims for this study were: 
1. To determine S. albulus growth rate in different carbon sources, ε-PL production and 
antimicrobial activity.  
The above parameters have been established previously in several studies; however 
these need to be set in our laboratory in order to use the data for downstream 
processes. 
 
2. To evaluate the commercial feasibility of ε-PL in terms of its use as a food preservative 
in Southern Africa. 
ε-PL has been used as a food preservative for staple foods in Japan, Korea and the 
United States but has not been introduced into the Southern Hemisphere to date. In 
addition, production of ε-PL using glucose as a carbon source to grow S. albulus is 
expensive and crude glycerol may reduce these costs making it economically feasible.  
 
 
3. To develop tools and protocols for two engineering strategies namely the group II 
intron TargeTron® gene knockout system and λ Red mediated recombineering system 
in S. albulus. 
Engineering systems have been developed in various Streptomyces species and more 
specifically in S. albulus. However these have been limited and the methods described 
above have not been attempted in S. albulus.  
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CHAPTER 2. STREPTOMYCES ALBULUS GROWTH AND 
ANTIMICROBIAL ACTIVITY 
 
2.1. INTRODUCTION 
ε-PL is a secondary metabolite produced naturally by S. albulus, a Gram positive, aerobic, 
filamentous and soil dwelling bacteria. It consists of 25-35 L-lysine residues, characterized 
by a peptide bond between the α-carboxyl and ε-amino group (Shima et al., 1984).  
The sole method of ε-PL production is by aerobic fermentation (pathway in Appendix 7.5) 
(Hamano et al, 2007; Shukla et al., 2012) and glucose is the conventional carbon source 
used by S. albulus for ε-PL biosynthesis (Shima et al., 1983). However, glucose is 
expensive and prices unstable; hence alternative carbon sources such as glycerol have 
been studied (da Silva et al., 2009; Chen et al., 2011).   
 
Glycerol has shown to be feasible as an intermediate in a number of metabolic processes 
in microorganisms for its use as a carbon source. Shima and Sakai, 1977, reported that 
wild-type S. albulus produced 0.3 g/L ε-PL after 96 hours of flask culture in a medium 
containing glycerol.  More recently it was shown that a combination of glucose to glycerol 
(weight ratio 1:1), produced 1.2 g/l of ε-PL (Shukla and Mishra, 2012). Nevertheless, the 
purifying costs of glycerol use is too high and therefore not economically viable (Johnson 
and Taconi., 2007). 
 
Since glycerol is both a cell metabolite and a carbon substrate for growth, residual, crude 
glycerol from biodiesel could be postulated as a substrate for microbial growth.  From 
every 100 kg of biodiesel produced 10 kg of crude glycerol is obtained via the 
transesterfication process. Crude glycerol (70-80 % pure) has little economic value 
because of the surplus in its production, lowering the price (Johnson and Taconi., 2007). 
To date, no effective use for crude glycerol exists. Therefore, new value added uses for 
crude glycerol are necessary, such as its use as a carbon source for bacterial growth. 
 
ε-PL has recently attracted significant attention due to its wide antimicrobial spectrum and 
high safety. It shows strong antimicrobial activity against Gram-positive and Gram-
negative bacteria, fungi and some viruses (Hiraki et al., 2003; Yoshida and Nagasawa, 
2003). It is these properties that make it suitable for use in the food and medical 
28 
 
industries. The antimicrobial activity is of interest for it to be considered an alternative 
natural food preservative.  
 
More specifically, it has shown antimicrobial activity against, S. aureus, Bacillus spp., 
Listeria Monocytogenes, Salmonella typhimurium,  E. coli, Pseudomonas spp., 
Camphylobacter jejuni, Micrococcus spp., Clostridium acetobutylicium (Geornaras et al., 
2007), Aspergillus niger, Fusarium oxysporum, Candida spp. and Penicillium spp. (Shih et 
al., 2006) in broth culture media. These however have not been validated on solid media.  
The aim of this chapter is to determine S. albulus CCRC 11814 growth rate in different 
carbon sources, ε-PL production and antimicrobial activity in our laboratory.   
 
 
2.2. MATERIALS AND METHODS 
2.2.1. Microorganisms 
The bacterium S. albulus CCRC 11814 was used throughout the study. It was obtained as 
a gift from Ing–Lung Shih from Da-Yeh University in Japan. The strain was stored as a 
glycerol stock at -70°C and thawed when required.  
 
2.2.2. Media and culture conditions 
Minimum medium containing per litre: 8 g NH4Cl, 0.5 g (NH4)2SO4, 0.3 g MgCl2.6H2O, 40 
mg  EDTA, 2 mg ZnSO4.7H2O, 1 mg CaCl2.H20, 15 mg FeSO4.7H2O, 0.2 mg  
Na2MoO4.2H2O, 2 mg CuSO4.5H2O, 0.4 mg CoCl2.6H2O and 1 mg MnCl2.4H2O was used 
for S. albulus growth. Media pH was adjusted to 6.8 (optimal pH for S. albulus growth) 
using 0.75 M K2HPO4 and 0.75 M NaH2PO4  buffers. pH was confirmed using a basic 20
+ 
pH meter (Crison instruments).  Growth conditions were maintained at 25 °C, which is the 
optimal temperature for general Streptomyces growth.  
 
2.2.3. S. albulus growth in various carbon sources 
Glucose (Merck chemicals), pure glycerol (Sigma-Aldrich) and crude glycerol were used 
as carbon sources to determine whether S. albulus has the ability to grow in their 
presence. The crude glycerol was obtained, as a gift, from a biodiesel producer in South 
Africa.  Previously, in our laboratory, it was shown that S. albulus can grow on glucose  
(2 %), hence, it was used as a positive control. The strain was grown in 1 L Erlenmeyer 
flasks containing 200 ml of minimum medium, with various concentrations of pure glycerol 
(2 %, 5 % and 10 %) and crude glycerol (1 %, 2% and 10 %).  Concentrations of crude 
glycerol were calculated based on the fact that the purity was 70 %. The experiments 
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were performed in triplicate and the flasks were incubated at 250C on a rotary shaker 
(Labcon) at 220 rpm.  
The different glycerol concentrations in the medium were used to determine the optimal 
level of carbon source utilised by the strain. From each sample, 1 ml was drawn daily 
using a sterile pipette, for cell density determination. Growth was measured using optical 
density (OD) at 660 nm with a UV-Vis spectrophotometer (PG instruments).  
 
2.2.4. Quantitative determination of ε-PL 
ε-PL was quantified using an original colorimetric method developed by Itzhaki in 1972. 
This method was adapted based on the interaction of ε-PL with an acidic, anionic dye, 
trypan blue (Shen et al., 1984). The dye and ε-PL form an insoluble complex and the 
remaining trypan blue is collected as a supernatant after centrifugation. The unbound dye 
is used to estimate ε-PL production at an absorbance of 580 nm. From each sample, 1 ml 
was mixed with 2.88 ml of 0.1 M saline buffer at pH 7 and 0.12 ml of 1 mg/ml trypan blue 
(Sigma-Aldrich) to make up a total volume of 4 ml. The mixture was placed on a rotary 
shaker (Labcon) at 30 0C for 30 minutes to allow for the reaction to occur. The water-
insoluble complex was centrifuged at 1600 x g for 10 minutes at 4 0C using a F15-8X50C 
rotor of a Sorvall RC 6+TM centrifuge. The supernatant was collected and the absorbance 
was measured using a T60 UV-Vis spectrophotometer (PG instruments). Commercially 
supplied ε-PL was used to prepare a range of concentrations of 200 mg/ml to 1000 mg/ml 
to plot a standard curve. Absorbance results from the standard curve were used to 
determine the concentration of ε-PL.  
 
2.2.5. Theoretical up-scaling: ε-PL production 
Theoretical up-scaling was performed using the CEBER Modeller developed by Dr Kevin 
Harding. This is an excel model which uses algorithms in order to upscale the production 
of compounds in terms of the media requirements and energy consumption. The model 
works by inputting lab scale figures obtained from experiments. The following lab scale 
inputs were selected: product composition (including media and bacteria), dry cell weight 
(DCW), amount of product produced and amount of product required at the end.  The up-
scaling was performed in order to predict media requirements as well as energy 
consumption for bioreactor and industrial fermentations.  
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2.2.6. Assessing the antimicrobial capabilities of ε-PL 
In order to assess the antimicrobial capabilities of ε-PL against both bacteria and fungi, 
two different experiments were set up. The ε-PL used for these experiments was obtained 
from a supplier.  
 
Antimicrobial effects against bacteria 
Nutrient agar (NA) plates containing different concentrations (50 µg/ml, 100 µg/ml and 200 
µg/ml) of ε-PL were made. The ε-PL was spread onto the plates after the solidification of 
the agar. 100 µl of standardised S. aureus, E. coli or P. aeruginosa bacterial suspension 
(by cfu/ml) was spread onto the plates and they were incubated for 24 hours at 37°C.  
 
Antimicrobial effects against fungi  
Potato Dextrose Agar (PDA) (Merck Chemicals) containing different concentrations (50 
µg/ml, 100 µg/ml and 200 µg/ml) of ε-PL were made. The ε-PL was spread onto the plates 
after the solidification of the agar. The plates were cross sectioned and an 8 mm diameter 
part of Aspergillus niger or Penicillium simplicissimum was placed in the centre using a 
sterile cork borer. The plates were incubated at 25°C until the growth of the control (0 
μg/mL ε-PL) reached the end of the plate. Diameter measurements were taken daily using 
three replicates. Rates of extension of fungal growth were calculated for both the 
experiment and control. These were used to calculate the growth index (GI), which 
represents the promotion or inhibition of fungal growth. The GI formula is: (E/C x 100) – 
100, where E and C represent the experiment and control rate of extension respectively 
(Chen and Jiang, 2001).  
 
2.3. RESULTS 
2.3.1. S. albulus growth 
Carbon Source 
S. albulus showed sigmoidal growth curves in the presence of pure and crude glycerol. 
Bacterial growth in the presence of glucose, was the fastest, followed by  
5 %, 1 0% and 2 % pure glycerol respectively (Figure 2.1). Crude glycerol showed slower 
growth compared to pure glycerol but growth was fastest in 5 %, 10 % and 2 % 
respectively (Figure 2.2).  
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Figure 2.1. Cell density represented by OD readings of S. albulus grown in shake 
flasks with different concentrations of pure glycerol and glucose as a control. 
Glucose was the best utilized carbon source followed by 5%, 10% and 2% glycerol 
respectively. The 5% containing glycerol medium showed a typical bacterial growth 
curve and was the best utilized carbon source. Results represent the means of 3 
replicates ± standard error of mean. 
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Figure 2.2. Cell density represented by OD readings of S. albulus grown in shake 
flasks with different concentrations of crude glycerol and glucose as a control. 
Glucose was the best utilized carbon source followed by 5%, 10% and 2% crude 
glycerol respectively. The 5% containing glycerol medium showed a typical bacterial 
growth curve and was the best utilized carbon source. Results represent the means of 
3 replicates ± standard error of mean.  
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2.3.2. ε-PL quantification 
The standard curve of absorbance and ε-PL concentration is shown in Figure 2.3. The 
trend shows that absorbance decreases with increasing concentration of ε-PL.  
 
 
 
 
 
 
 
 
 
 
ε-PL was produced in the presence of both pure and crude glycerol of all concentrations 
(Figure 2.4). The highest amount of ε-PL is produced using 2 % glucose as the carbon 
source followed by 10 % pure glycerol, 5 % pure glycerol and 2 % pure glycerol (blue 
bars). With regards to the crude glycerol (red bars), the highest concentration of ε-PL was 
produced at 10 %, followed by 2 % and 5 %.  
 
 
 
 
 
 
 
 
 
 
 
 
y = -0.007x + 0.955 
R² = 0.977 
0
0.2
0.4
0.6
0.8
1
1.2
0 200 400 600 800 1000 1200
A
b
s
o
rb
a
n
c
e
 a
t 
5
8
0
 n
m
  
Concentration of ɛ-PL (mg/l) 
Figure 2.3. Calibration curve of mean absorbance vs concentration of ε-PL (mg/l). 
The graph shows that the absorbance decreases with increasing concentration of ε-PL.  
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Figure 2.4.  Amount of ε-PL produced by S. albulus bacteria. The carbon source 
utilised for this experiment was pure and crude glycerol. On average, half the amount of 
ε-PL is produced using crude glycerol compared with pure glycerol.  Results represent 
the means of 3 replicates ± standard error of mean. 
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2.3.3. Up-scaling ε-PL production 
The theoretical up-scaling of ε-PL production on an industrial scale will produce  
41192.5 kg/year of crude product with a recovery rate of 92.18 % and a purity of 94.87 %. 
This will require the input of 1585 kg of S. albulus as well as several other media sources. 
This industrial upscale will produce a large amount of waste of which the majority 
attributed to bacteria (835800 kg) as well as large emissions of oxygen, nitrogen and 
carbon dioxide producing 18630 tons, 83000 tons and 4525 tons respectively (Table 2.1).  
 
Table 2.1. The theoretical product output, input of materials and waste emitted for 
the up-scaling of ε-PL on an industrial scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Material Amount Unit 
Product out-
put 
Product Name  Lysine   
Total Product Mass 41192 kg 
Purity 94.87 % 
Recovery  92.18 % 
IN 
Electricity 56810 GJ 
Steam 2614 ton 
Cooling water 596900 m3 
Municipal water 272.9 m3 
Distilled water 15850 m3 
Antifoam 152300 kg 
Streptomyces albulus 1585 kg 
Carbon source 991100 kg 
Oxygen 22040000 kg 
Nitrogen 82920000 kg 
Nitrogen feed (Fertilizer) 708400 kg 
Ammonia sulphate 398500 kg 
Buffer 105100 kg 
Waste 
Water 18370 m3 
Antifoam 152300 kg 
Streptomyces albulus 835800 kg 
Carbon source 9813 kg 
Nitrogen feed 33730 kg 
Ammonia sulphate 18980 kg 
Buffer 5003 kg 
Lysine 3316 kg 
K (ions) 44920 kg 
Nett air 
emissions 
Oxygen 18630000 kg 
Nitrogen 83000000 kg 
Carbon dioxide 4525000 kg 
Solid waste None 0 kg 
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Energy consumption results show that most of the energy (82 %) will be used up during 
the agitation process of microbial growth and product formation. The remainder of the 
energy is used for aeration (14 %) and post fermentation processes (4 %) such as product 
purification (Figure 2.5). 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.4. Antimicrobial activity of ε-PL 
 
Antimicrobial effect against bacteria 
ε-PL showed the inhibition of growth of both S. aureus and E. coli and had no effect on the 
growth P. aeruginosa.  
The control S. aureus showed growth throughout the entire plate, while at 50 µg/ml only 
several isolated colonies were seen (indicated by the red circles). No growth was seen on 
the 100 µg/ml and 200 µg/ml plate (Figure 2.6). The murkiness of the plates is attributed 
to the ε-PL that was spread onto the plate after solidification.  
 
 
 
 
4% 
82% 
14% 
Microbial
growth/Product
formation - Post
fermentation
Microbial
growth/Product
formation - Agitation
Microbial growth/
Product formation -
Aeration
Figure 2.5. The energy consumption during the manufacturing of ε-PL on a large 
scale. The figure shows the energy allocations for several processes in microbial 
growth/product formation.  
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The plates containing E. coli showed a similar trend whereby the control plate and the  
50 μg/ml was covered in a lawn of bacteria, whereas the plates containing ε-PL showed 
no growth (Figure 2.7).  
 
 
 
 
 
 
 
 
Figure 2.6. The growth of S. aureus in a solid model system containing varying 
concentrations of ε-PL. The bacteria was grown on NA plates. (a) No ε-PL. (b) 50 
µl/ml. (c) 100 µl/ml. (d) 200 µl/ml. 100 µl of bacterial suspension was added to each plate 
and incubated at 37°C for 24 hours. 
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P. aeruginosa showed a lawn of growth on the control plate as well as on the experiment 
plates for all three concentrations (Figure 2.8).  
 
 
 
 
 
 
 
 
 
Figure 2.7. The growth of E. coli in a solid model sytem containing varying 
concentrations of ε-PL. The bacteria was grown on NA plates. (a) No ε-PL. (b) 50 
µl/ml. (c) 100 µl/ml. (d) 200 µl/ml. 100 µl of bacterial suspension was added to each plate 
and incubated at 37°C for 24 hours. 
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Antimicrobial effect against fungi 
ε-PL did not show significant inhibition of A. niger growth as compared with the control 
(Figure 2.9). The A. niger extension rates (Rp:RC) were 1.25, 0.5 and 1.25 for ε-PL 
concentrations of 50 μg/ml, 100 μg/ml and 200 μg/ml respectively.  
ε-PL showed some inhibition of P. simplicissimum  growth as compared with the control 
(Figure 2.10). The P. simplicissimum extension rates (Rp:RC) were 0.66, 0.13 and 0.2 for 
ε-PL concentrations of 50 μg/ml, 100 μg/ml and 200 μg/ml respectively.  
 
 
 
 
 
A B 
C D 
Figure 2.8. The growth of P. aeruginosa in a solid model system containing 
varying concentrations of ε-PL. The bacteria was grown on NA plates. (a) No ε-PL. (b) 
50 µl/ml. (c) 100 µl/ml. (d) 200 µl/ml. 100 µl of bacterial suspension was added to each 
plate and incubated at 37°C for 24 hours.  
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Figure 2.10. The growth (mm) of P. simplicissimum on PDA agar plates in the 
presence of different concentrations of ε-PL as well as a control over a period of 
time(days). Results represent means of 6 values and error bars indicate ± standard 
error of mean. The figure shows the growth of the fungus P. simplicissimum on PDA agar 
plates, containing different concentrations of ε-PL (50 μg/ml; 100 μg/ml and 200 μg/ml) 
as well as control plate containing no ε-PL. 
Figure 2.9. The growth (mm) of A. niger on PDA agar plates in the presence of 
different concentrations of ε-PL as well as a control over a period of time(days). 
Results represent means of 6 values and error bars indicate ± standard error of mean. 
The figure shows the growth of the fungus A. niger on PDA agar plates, containing 
different concentrations of ε-PL (50 μg/ml; 100 μg/ml and 200 μg/ml) as well as control 
plate containing no ε-PL. 
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The GI for A. niger and P. simplissimum is shown in Figure 2.11. The growth of P. 
simplissimum was inhibited by all concentrations of ε-PL, with the highest percentage at 
100 μg/ml. A. niger growth was promoted at 50 μg/ml, 100 μg/ml and 200 μg/ml.  
 
 
 
 
  
 
 
 
 
 
 
 
2.4. DISCUSSION 
S. albulus growth  
Based on the growth experiments, S. albulus shows faster growth in the presence of 
glucose, as opposed to pure and crude glycerol. There are several possibilities for this: 
Firstly, bacterial glucose metabolism is faster than glycerol due to its 6-carbon molecule 
and therefore, completes two cycles with one mole as compared to 2 moles of a 3-carbon 
molecule glycerol. Secondly, glycerol enters the microbial cells by facilitated diffusion and 
the rate at which the strain takes up this substrate is dependent on the effectiveness of 
the uptake process (Papanikolaou et al., 2008). E. coli has a glycerol facilitator protein, 
responsible for glycerol uptake whereas the uptake of glycerol by Streptomyces spp is not 
documented (Voegele et al., 1993). It is this non-selective glycerol facilitator protein that 
allows E. coli to utilise glycerol at higher rate as compared to S. albulus. Thirdly, glycerol 
viscosity hinders oxygen transfer, which reduces the growth rate because S. albulus is an 
aerobic organism (Pachauri and He, 2006). Lastly, there is a lack of information on the 
chemical composition of crude glycerol as a feedstock in industrial processes. Crude 
glycerol purity is dependent on the substances used in its production process (Gonzalez-
Pajuelo et al., 2005). 
Figure 2.11. The growth promotion or inhibition of A. niger and P. simplissimum in 
the presence of different concentrations of ε-PL. The growth of P. simplissimum was 
inhibited by all concentrations of ε-PL, with the highest percentage at 100 μg/ml. A. niger 
growth was promoted at 50 μg/ml, 100 μg/ml and 200 μg/ml. 
 
-100
-80
-60
-40
-20
0
20
40
50 100 200
%
 g
ro
w
th
 p
ro
m
o
ti
o
n
 o
r 
in
h
ib
it
io
n
 
ε-PL concentration (μg/mL) 
A. niger
P. simplicissimum
40 
 
S. albulus showed the ability to grow in the presence of crude glycerol. This result is very 
interesting as very few microorganisms can actually utilize crude glycerol (Rumbold et al., 
2010). Growth in crude glycerol was slow as shown by the lower growth rates possibly 
due to impurities (Sneha et al., 2009). Crude glycerol contains between 15 – 30% 
impurities in the form of methanol, fat or oil remains and sodium or potassium hydroxide 
(Çelik et al., 2008).  Such impurities would lengthen the lag phase as the strain adapts to 
the new environment. Growth inhibition is probably due to high levels of sodium and 
methanol used in biodiesel production (Rumbold et al., 2009). 
 
ε-PL production 
ε-PL produced in this study, using 2 % glucose was 1.06 g/L, which differs to the original 
amount of 0.2 g/L reported by Shima and Sakai, (1977), when a wild strain of S. albulus 
was grown in a basal medium containing glucose. However, it is similar to the amount 
produced by Hiraki et al., (1998) which was, 1.2 g/L.  The slight differences in the amount 
of ε-PL produced may have been as a result of a lack of pH monitoring in this study as 
well as the strain used.  
The concentration of ε-PL produced in the presence of 2 %, 5 % and 10 % pure glycerol, 
0.97 g/L, 0.98 g/L and 1.04 g/L are similar to the 1.2 g/L reported by Hiraki et al., (1998) 
and 1-3 g/l reported by Hamano et al., (2007).  
The ε-PL concentrations in the presence of crude glycerol were half of that obtained in 
glucose and pure glycerol. Due to the impurities found in crude glycerol, the bacterium is 
under stress and requires adaptation. Therefore more energy is used overcoming the 
stress than on secondary metabolite production.  
Recently, an advantage of using glycerol as a carbon source for ε-PL production has been 
elucidated.  Glycerol is beneficial to the production of low molecular weight ε-PL. ε -PL 
with fewer lysine residues produces a more pleasant taste when used as food 
preservative (Chen et al., 2013). In addition, recent research has suggested that a 
combination of glycerol and glucose in a 1:1 ratio produced 5.26 g/L (Chen et al., 2012), 
which is higher than 1.2 g/L reported previously (Hiraki et al., 1998) 
 
 
Antimicrobial activity 
On average, ε-PL has been shown to inhibit growth in a wide variety of organisms at 
concentrations of approximately 100 µg/mL (Yoshida and Nagasawa, 2003). This forms 
41 
 
part of the reasoning behind the selection of the three concentrations for the antimicrobial 
experiments.  
S. aureus, a Gram positive bacteria was found to be completely inhibited by ε-PL at a 
concentrations of 100 µg/ml. The relevance of observing ε-PL activity against S. aureus is 
because it is a common cause of skin and soft tissue infections. Moreover, treatment of S. 
aureus infections in hospitals is ineffective because some of bacteria show resistance to 
multiple antibiotics. These pathogens are referred to as methicillin resistant S. aureus 
(MRSA) (Fridkin et al., 2005). Future work could involve obtaining samples of known 
MRSA and observe the antimicrobial activity of ε-PL against them.  
Similarly E. coli, a Gram negative bacterium, growth was inhibited at a minimum 
concentration of 100 µg/ml. E. coli was selected due to the fact that it is such a common 
bacteria, it is a representative of the Gram negative group and may cause gastroenteritis.  
P. aeruginosa, a bacterium responsible for responsible for causing chronic and fatal 
infections of lungs in cystic fibrosis patient’s, growth was not inhibited by ε-PL. These 
bacteria are soil inhabitants and therefore require mechanisms of resistance to compete 
with Streptomyces. There has been evidence to suggest that a few isolates of P. 
aeruginosa are resistant to all reliable antibiotics due to low outer membrane permeability. 
(Livermore, 2002; Breidenstein et al., 2011). The permeability is 12–100 times less than 
that of E. coli (Hancock, 1998). The outer membrane of Gram negative bacteria acts as a 
selective barrier to uptake of antibiotics (Nicas and Hancock, 1983).  P. aeruginosa was 
selected as it is important to look for new antibiotics that would have the ability to inhibit or 
reduce the growth of P. aeruginosa.  
 
The bacterial antimicrobial studies were performed using solid media to imitate the texture 
of solid food products. It would also be beneficial to perform similar studies using liquid 
media and obtaining colony forming unit (cfu) counts (Zheng, 2014) to gain quantitative 
insight into ε-PL antimicrobial activity as opposed to only qualitative.  
 
With regards to antimicrobial activity against fungi, the GI was used as a measure of 
fungal growth promotion or inhibition. The GI is expressed as a percentage, whereby 
negative values indicate fungal growth inhibition and positive values fungal growth 
promotion (Chen and Jiang, 2001).  A. niger was selected as it is a common contaminant 
of food (Ramesh et al., 2013).  This fungi was not inhibited by ε-PL but P. simplissimum 
showed inhibition at the lowest concentration of 50 μg/mL.  A possible reason for ε-PL 
being ineffective against A. niger is its ability to depolymerise the polymer, thus changing 
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its structure and hence function.  There have been studies showing that strains of A. niger 
are capable of producing proteases (Punt et al., 2008; Mukhtar and-Ul-Haq, 2009). 
Significance of antimicrobial activity against both A. niger and P. simplissimum was 
evaluated using a student’s T test. P. simplissimum were shown to be significant at a  
95 % confidence level. T test results for A. niger were not shown to be significant, possibly 
due to the similarity of the growth rates between the control and treated samples (Data 
shown in Appendix 7.7).  
The results shown in these experiments coincide with original minimum inhibitory 
concentration (MIC) performed by Shima et al., (1984). However, the experiments are 
based on the fact that the antimicrobial activity of ε-PL is dependent on its molecular size, 
which was unknown in these experiments.  
 
Upscaling 
The significance of the results obtained from the theoretical up-scaling model, 
demonstrate the need for extensive waste removal operations when producing a product 
on an industrial scale. These results would be applicable for media costing and waste 
removal activities in Chapter 4.  
An area of growing concern worldwide is global warming which places greater demands 
on reducing CO2 emissions. Due to the high emissions of CO2, in the production of ε-PL 
process there is a need to introduce energy and cost efficient removal methods. Most 
recently, adsorption and membrane separation have been studied as the best method of 
CO2 removal in industry (Ebner and Ritter, 2009). 
 
2.5. CONCLUSION 
In conclusion, based on these experiments, S. albulus has the ability to grow and produce 
ε-PL in the presence of crude glycerol. This growth and ε-PL production in the presence of 
crude glycerol is not optimal. ε-PL showed antimicrobial activity against two bacteria,  S. 
aureus, E. coli as well as a fungi, P. simplissium. The secondary metabolite did not inhibit 
the growth of P. aeruginosa or A. niger.  
Due to the fact that S. albulus has the ability to grow in crude glycerol, it could be used as 
an economically viable way to produce ε-PL for use as a food preservative in South Africa. 
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CHAPTER 3. THE COMMERCIAL FEASIBILITY OF EPSILON 
POLYLYSINE AS A FOOD PRESERVATIVE 
 
3.1. INTRODUCTION 
In order to determine whether there is a market available for ε-PL production in South 
Africa, several crude figures around the production and cost of ε-PL need to be taken into 
account. The average cost of polylysine is $ 3000/kg and on an industrial scale, 
fermentations on average can produce 40 g/L using a 5 L jar fermenter (Kahar et al., 
2002). Running the fermenter will require man power costing approximately $ 220 a day 
per individual and thus 3 individuals would cost $ 660 per day. There are currently many 
different preservatives available on the market and, for example, the cost of a single one 
such as sodium benzoate is US $ 1,340 - 1,355 / 1000 kg (Food preservatives, 2012). 
Thus the ε-PL production market has an opportunity to create profit in terms of its use as a 
preservative compared with the use of current preservatives although a much deeper 
analysis of the commercial and economic feasibility of the product is required.  
The aim of this chapter is to evaluate the commercial feasibility of ε-PL in terms of its use 
as a food preservative in Southern Africa. This will be achieved through the study of a 
hypothetical company called PεL Biosciences which will manufacture and sell the ε-PL 
under a product name of FoodSafe. The commercial feasibility will be presented in the 
form of a business plan.  
 
3.2. Executive summary 
PεL Biosciences (pronounced Pel) is being established to manufacture and distribute a 
natural food preservative known as FoodSafe, initially for fresh prepared chicken in the 
South African market. FoodSafe is a safe, non-allergenic, odourless, tasteless and 
colourless natural peptide derived from bacteria (Hiraki et al., 2003). It significantly 
extends the shelf-life of fresh produce, including meat, fruit and vegetables, whilst at the 
same time maintaining important consumer valued characteristics of smell, colour, texture, 
taste and the overall appearance of product freshness (JNC, 2013).  
 
FoodSafe offers the following key benefits (JNC, 2013):  
 Consumers of chicken and fresh produce value the freshness characteristics 
especially at the time of purchase.  
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 The ability to extend the lifespan of such produce adds value to retailers and 
consumers by reducing the waste of valuable produce stock by retailers, and by 
consumers after purchase.  
 Since FoodSafe is a natural preservative, it is preferred by many consumers who 
perceive health risks associated with chemical preservatives  
 FoodSafe has proven to maintain nutritional value, texture and flavour and is thus 
an extremely attractive product for food preservation. It acts by eliminating the 
growth of micro-organisms that typically cause spoilage and extends the typical 
shelf life of refrigerated chicken (which is cheaper to store than frozen chicken) 
and avocados by at least twice over for both products, or by an additional 4 days 
for chicken and an additional week for avocados.  
 
Initially, the focus will be on the development and marketing of FoodSafe for chicken 
producers, specifically RCL Foods Ltd. (formerly Rainbow Chickens). Chicken has been 
shown to contain the highest microbial content of all meats and it has further been shown 
that extensive processing further increases the microbial population (under uncontrolled 
conditions). The focus on the company’s Farmer Brown brand as RCL Foods has 
indicated a need to increase the shelf life of refrigerated chicken. This brand is wholly 
focused on supplying premium quality refrigerated fresh chicken that is extensively 
processed, i.e. trimmed of excess skin, fat and bone. There is a large local market 
opportunity (19 million chickens produced per week by RCL Foods Ltd) which we hope to 
corner with the use of FoodSafe.  
 
Engagement and involvement with chicken producers at this early stage will enable us to 
tailor the FoodSafe product application during routine processing either via sprays, or 
dips, which is an established part of their production processes. This will determine how 
best it should be produced and supplied at the scale relevant to a particular client’s food 
and packaging production process needs. Once established in this large volume market, 
we then intend to expand to other meats as well as fruits and vegetables (for example 
high value produce such as avocados which producers have indicated interest for shelf 
life extension, using a natural product for export markets). The application of the powder 
requires tailoring and testing for each type of produce, and this will be a key service we 
will provide to initially the Southern African, and in time southern hemisphere, products 
and produce, where similar products are not available.  
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3.3. Description of proposed product  
FoodSafe is a natural polypeptide produced by bacteria and would typically be sold in the 
form of a white powder. It can be applied to fresh or processed food by either directly 
spraying a solution of FoodSafe and water onto the food product, or briefly immersing the 
food product into a solution of FoodSafe and water of appropriate concentration as part of 
the production process. Alternatively, FoodSafe can be added to the dry ingredients of a 
food prior to baking, cooking or other form of product finalisation. FoodSafe can also be 
used alone or in conjunction with other preservatives, and has been shown to have 
synergistic effects when combined with other preservatives (a concept known as hurdle 
technology). The combination of preservatives improves FoodSafe’s antimicrobial activity 
significantly.  
 
FoodSafe has several desirable features and benefits:  
 Water soluble – can easily combine with water at an appropriate concentration for 
the application, and either sprayed onto food or have food immersed into the 
solution (Hiraki et al., 2003);  
 Heat stable – food cooked at high temperatures would not cause removal or 
degradation of the preservative as it will remain on the food-product surface and 
maintain its action (Hiraki et al., 2003);  
 Non-toxic and biodegradable – has no negative effects on human and animal 
health as well as the environment (Hiraki et al., 2003);  
 Tasteless – the product would not influence the taste of the food product to which 
it is applied (Zheng, 2014);  
 Healthy – contains the essential amino acid lysine which is not naturally produced 
by the body. Lysine is essential for growth and plays a vital role in the production 
of carnitine which is responsible for converting fatty acids into energy and lowering 
cholesterol. Lysine also helps the body absorb calcium, and therefore the 
formation of collagen, a substance important for bones (Singh et al., 2005);  
 
3.4. Technology Solution and readiness 
The following work has been conducted to demonstrate that the offering has potential to 
work and is practically implementable: 
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1. The results of experiments conducted in our laboratory have shown that the 
bacteria can grow using a waste feedstock (crude glycerol) to improve the 
economic feasibility of ε-PL production (results shown in Chapter 2).  
 
2. The results of experiments conducted in our laboratory have shown that the 
current strain, S. albulus 11814 can produce ε-PL (results shown in Chapter 2).  
 
3. Experiments conducted by JNC Corporation, provide a clear indication that at 
appropriate concentrations, the levels of bacteria (E. coli – 1.1 x 104 cfu/g) present 
in fresh meat can be reduced over time thereby improving shelf life and food 
safety. Acceptable levels of bacteria are 1000 bacteria per ml (JNC Corporation 
Data, 2013). The graph below shows that ε-PL is successful in maintaining 
declining bacterial numbers when using a ε-PL concentration of 400 ppm (Figure 
3.1).  
 
 
 
 
 
 
 
 
 
 
 
We intend to conduct further experiments to show the effectiveness of our product on 
chicken, and further wish to validate that our product is similar and comparable in 
performance to that of JNC Corporation. The necessary studies required to obtain 
regulatory approval will be conducted, and these will be performed during the first year to 
Figure 3.1. The effectiveness of ε-PL against E. coli on meat products. The figure 
shows the number of bacteria (cfu/ml) on meat decreasing after 48 hours in the 
presence of ε-PL of 400 parts per million (ppm) at an original bacterial concentration of 
1.1 x 104 cfu/g. In the absence of ε-PL there is an increase in the number of bacteria 
(JNC data, 2013).  
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achieve product registration as a safe human food additive in terms of Joint FAO/WHO 
Expert Committee on Food Additives (JECFA).  
Beyond this we will establish a commercial scale production facility that will produce 
FoodSafe using waste glycerol as a feedstock at sufficient volumes to support our sales 
drive. We also intend to undertake work aimed at improving yields of FoodSafe via genetic 
modifications of the production bacterium, and therefore lowering the cost of production. 
This modification would only improve the yield of product and will in no way change its 
properties.  
 
3.5. Competitor analysis and competitive advantage 
As far as we are aware, the biggest competitor is JNC Corporation, who claims to be the 
sole provider of ε-PL for food products in the Northern hemisphere. There are also a few 
other sellers of the product in China, however these are for small scale use such as 
research or other medical applications of the product. These include: Hangzhou Uniwise 
International Co., Ltd and Zhengzhou Sigma Chemical Co., Ltd. A summary of different 
factors of our company and the three known competitors (Table 3.1). 
 
 
 
 
 
 
 
 
 
 
 
The table summarises PεL Biosciences and three competitors in terms of ε-PL and its sale. The 
main factors compared are price, quality, product features and delivery. PεL Biosciences is both 
competitive in price as well as rapid product delivery due to market proximity as opposed to the 
competitors.  
 
PεL Biosciences JNC Corporation
Zhengzhou Sigma 
Chemical Co., Ltd.
Hangzhou Uniwise 
International Co., 
Ltd
Low Price
R3500/kg (including 
delivery)
Price on Request
R2500/kg (excluding 
delivery and import 
taxes)
Price on request
Superior Quality
Customisable product
Have the ability to 
customise to different 
foods based on reasearch
Have the ability to 
customise to different 
foods based on reasearch
Purchase Powder 
Only
Purchase Powder 
Only
Unique Features
Method of production 
Unique
Unknown Unknown Unknown
Rapid Product Delivery
Yes - manufactured in 
South Africa
No - Import from abroad
No - Import from 
abroad
No - Import from 
abroad
The same product with the same properties
Companies
Factor
Table 3.1. A summary of the competitive factors between our company and three 
other identified competitors. 
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The competitive advantage: 
 Proximity to market and the types and packaging of fresh produce in the local 
markets; 
 Ability to tailor specific products in collaboration with our major clients both for 
local sales and high value produce for export; 
 In time, increasing price competitiveness as volumes increase. While with JNC, 
price information is only available through a consultation process specific to the 
customer’s application of poly-lysine, our product is available at a fixed price 
per kilogram and the product formulation consultation will be done free of 
charge on an exclusivity basis and;  
 Lastly we aim to offer rapid product delivery as opposed to competitors who 
are located overseas. 
 
3.6. National benefit 
Promoting postgraduate involvement in our business. In order to promote this initiative we 
would like to outsource the skills of outstanding current postgraduate and graduate 
students. This would involve post graduate students to participate in the research aspect 
of the business and assistance in the diversification of products  
 
In addition FoodSafe aims to promote food security throughout rural areas in South Africa 
to decrease food loss as well as foodbourne diseases.  
 
Lastly a large scale production facility producing large volumes of our product after 
several years will promote job creation for both very skilled and less skilled individuals. 
 
3.7. Market Analysis 
3.7.1. Basic global statistics 
On average one-third of edible foods produced are lost or wasted globally, which is equal 
to about 1.3 billion tonnes per year. Food is wasted from initial agricultural production 
through to final household consumption. Significant food loss and waste usually occurs 
early in the food supply chain. In low-income countries food is mainly lost during the early 
and middle stages of the food supply chain and much less food is wasted at the consumer 
level. (Gustavsson et al., 2011).  This provides the opportunity for intervention in these 
early and middle stages by introducing a suitable food preservative.  
49 
 
3.7.2. Basic South African statistics 
According to recent statistics produced by the CSIR, annual food production in South 
Africa amounts to 28.8 million tons. Of that 9.04 million tons goes to waste which equates 
to 31.4% of food wastage per annum. That equals to 177 kg of waste per capita per 
annum amounting to R61.5 billion loss in revenues.  
The majority of food is lost during the processing and packaging stage of production 
accounting for 27 %. This is followed by agricultural production and post harvest handling 
and storage which both account for 26 %. The least amount of food is lost during the 
consumer consumption process accounting for 4 % (Figure 3.2) (Oelofse and Nahman, 
2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
The major food commodity contributing to most loss are fruit and vegetables (47 %). This 
is followed by cereals, roots and tubers, milk and meat contributing 28 %, 10 %, 8% and 5 
% respectively (Figure 3.3) (Oelofse and Nahman, 2007). 
 
 
Figure 3.2. Percentage contribution of each step in the food supply chain to total 
average food waste in South Africa. The majority of food is lost during processing and 
packaging (27 %), followed by agricultural and post harvest handling and storage which 
both account for 26 % (Oelofse and Nahman, 2007). 
26% 
26% 
27% 
17% 
4% 
Agricultural production
Post Harvest handling and
storage
Processing anf Packaging
Distribution
Consumption
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Figure 3.3.  Percentage contribution of each commodity group to total average 
food loss in South Africa.  Fruits and vegetables show the highest percentage lost, 47 
%, followed by cereals which account for 28 % (Oelofse and Nahman, 2007). 
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3.8. Value creation 
In order to understand, where the value of the product lies, the chain from the supplier of 
the product all the way through to the consumer needs to be studied. The value of ε-PL 
lies in the wholesaler because the earlier the intervention for preservation the higher the 
quality of the product at the customer level as majority of food is lost during packaging and 
distribution.  Figure 3.4 shows the value chain specifically for the chicken industry in South 
Africa. 
 
 
 
 
 
 
3.9. Proposed route-to-market/commercialisation strategy 
The first step in the route to market is the registration of the food product in the South 
African market: 
Figure 3.4. The chicken industry production chain from the supplier to the 
customer. The addition of ε-PL would be most valuable at the wholesaler stage. This 
allows early intervention and the maintenance of high quality food for the consumer.  
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3.9.1. Registration of FoodSafe 
The first step for our business is to get the food preservative registered.  Our product has 
not been listed in the regulations under the Foodstuffs, Cosmetics and Disinfectants 
(FCD) Act of 1972. In SA, only preservatives that have been evaluated by the JECFA can 
be considered as safe and used commercially. This is because there is not enough 
expertise in S.A. to scrutinise new additives for use in food.  
 
South Africa uses the Codex Alimentarius as reference in determining the acceptability of 
a food additive. The list of codex specifications for food additives document from 2013 
was read thoroughly and poly-lysine was not found.  For an additive (other than a 
processing aid) not listed by Codex, a lengthy process to request inclusion in the Codex 
lists for food additives is followed. Two documents need to be submitted during a ‘call for 
data’ procedure to the JECFA.  These documents include: 
 
 Guidelines for the preparation of toxicological working papers for the Joint 
FAO/WHO Expert Committee on Food Additives and 
 Guidelines for the preparation of working papers on intake of food additives for the 
Joint FAO/WHO Expert Committee on Food Additives. 
 
The compilation of documents to be submitted to JECFA is underway and the evaluation 
process will take approximately 2 months. The people responsible for the compilation of 
information will be Valerie Bekker and Itumeleng Makhale, as well as other members of Dr 
Karl Rumbold’s lab who participated in any experimental work performed towards the 
business. After this, the panel will evaluate whether the product will be accepted or not. 
Our advantage in this case is that the product has already been registered with the U.S. 
Food and Drug Administration (FDA). The price and the total time for the registration of 
food additives could not be obtained and was estimated in the financial model based on 
other food registration committee’s prices.  
 
3.9.2. Antimicrobial Studies 
Preliminary antimicrobial studies using total cell counts and cell viability counts on skinned 
and skinless chicken have shown a decrease of microorganisms in the presence of  
100 μg/mL of ε-PL.  
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3.9.3. Pilot Manufacturing 
Contract Manufacturing 
For the first year of selling the business will make use of contract manufacturing available 
through the CSIR. The Bio-manufacturing Industry Development Centre (BIDC) is 
a CSIR initiative, in partnership with the eGoliBio Incubator and is supported by the 
Development Bank of South Africa (DBSA) through the Jobs Fund programme. The BIDC 
will utilise the funds made available by the Jobs Fund programme to provide product and 
process development support to small and medium enterprises (SMEs) in the bio-
manufacturing sector, with the aim of creating or expanding bio-manufacturing activity and 
associated job creation. Support will be provided to any qualifying biotech-based 
enterprises and/or entrepreneurs. The Centre’s unique infrastructure is housed at a new 
facility on the CSIR campus in Pretoria and offers bioprocess development infrastructure 
from lab to pilot scale, including upstream reactors from 1 L to 200 L, as well as the 
necessary downstream processing, formulation and analytical support for process 
development. Below are some of the key offerings of the BIDC: 
 Bio-manufacturing infrastructure and skilled human resource support (scientists, 
technologists, process engineers); 
 Technical and business incubation support; 
 Bio-based product development, formulation, and packaging; 
 Support in developing bankable business plans; and 
 Mentoring and training in business development and manufacturing skills. 
 
An application has been sent to the CSIR and is currently under evaluation. If our 
business is selected by the advisory panel, the support will be provided free, but the cost 
of the support will be tracked and will be recovered from the business only if there will be 
a cash positive business (on a levy-on-sales basis). The amount to be recovered will only 
be discussed if the business is selected.  
 
3.9.4. Full Scale Production 
Once the business is established building a larger facility can be considered. Based on 
current output, competitor demand, the success of the product and business projections, 
this upscale would be realistic after 4 years. This phase will involve our own 
manufacturing, where we will hire one production manager as well as two technicians to 
run it. This plant will use a 5000 L bioreactor able to produce 600 kg of the product per 
month, and will involve an average of 4 runs of the reactor per month. The product will 
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then be packaged on site and delivered to RCL Foods’ main distribution centre in 
Gauteng, who would re-distribute FoodSafe to their facilities. An agreement will be signed 
on the annual amounts of FoodSafe which will be purchased by RCL Foods.  
 
3.9.5. GMP Certification and Approval 
Prior to building a production facility, this would need GMP approval (Good Manufacturing 
Practices). Thereafter the large-scale facility will be built to produce FoodSafe as a food 
additive.  
 
3.10. Economic and financial returns 
There will be no revenues or profit during first year, as product registration and generating 
appropriate testing data for FoodSafe will be the on-going tasks. During that time, the 
product will be obtained as a gift from the Rumbold Lab at Wits University, for testing 
purposes. 
During the second year, we anticipate that the CSIR, or another contract manufacturer, 
will be producing FoodSafe at pilot scale at an assumed cost of R2 000 per kilogram, in 
order to decrease our initial capital costs significantly. In our analysis this is the more cost 
effective way of introducing the product, and as off take volumes increase, we will be build 
a full scale facility. In years 2 to 4, our model assumes that the majority of the product will 
be sold to RCL Foods Ltd, and in due course other fresh meat producers at a cost of R3 
600 per kilogram. Our analysis is that one chicken requires ~0.4g of FoodSafe powder. 
Since RCL Foods sells 20 million chickens per week, our full scale production facility that 
can produce 7 200kg of FoodSafe per year, addresses only a small fraction of that market 
per year. Therefore we believe our volume growth predictions are extremely conservative. 
Fruit & Vegetable suppliers sales (see Production Volumes tab, Financial Model) will start 
in low volumes (i.e. the remainder of sales after RCL Foods) for evaluation purposes, and 
from year 4 these volumes are expected to ramp up.  
We anticipate that sales to RCL Foods will steadily increase as we project that uptake of 
the product by the organisation will be in low volumes initially. Our contract pilot facility will 
have the capacity to match the increasing demand. 
We will request the majority of the investment cost to construct the full-scale facility at the 
beginning of the 4th year. This is in order to reduce the impact on profits, and to make the 
investment a performance incentive over the pilot phases (Year 2 – Year 4). 
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FoodSafe prices will increase from the 5th year as the value of the product is fully realised 
in the market, and price increases are likely to be well tolerated 
Below is a figure summarizing the income statement by showing the projected revenues, 
gross profits and net profits after tax over a 12 year period, for the above described 
conservative scenario, the single reactor production facility (Figure 3.5). 
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1 2 3 4 5 6 7 8 9 10 11 12
Total revenue R- R806 400.0 R1 080 000 R1 202 400 R9 899 000 R16 910 00 R54 720 00 R54 720 00 R60 040 00 R61 560 00 R63 080 00 R64 600 00
Gross profit R(316 400. R80 415.00 R167 967.0 R(903 600. R2 963 677 R8 359 137 R31 808 67 R31 035 80 R34 817 06 R35 934 08 R37 014 86 R38 095 40
Net Profit/Loss After Tax R- R358 400.0 R480 000.0 R534 400.0 R7 660 318 R14 671 31 R47 257 72 R47 257 72 R52 577 72 R54 097 72 R55 617 72 R57 137 72
 R(20 000 000.00)
 R(10 000 000.00)
 R-
 R10 000 000.00
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 R30 000 000.00
 R40 000 000.00
 R50 000 000.00
 R60 000 000.00
 R70 000 000.00
C
u
m
u
la
ti
v
e
 a
m
o
u
n
ts
 (
M
il
 o
f 
R
a
n
d
s
) 
Period of operation (years) 
Figure 3.5. Projected revenues and profits of PεL Biosciences over a 12 year period. Amounts presented are in millions of Rands. A 
logarithmic trend of Net profit/loss after tax is indicated by the black line. Breakeven will occur in year five of business operation. 
56 
 
It should be noted that in light of the low volumes of chickens that will be treated with 
FoodSafe, and the above production facility assumptions, there is a more optimistic 
scenario that could be sketched. Taking into account the positive cash flows available in 
the business, we could double our production capability to meet potentially higher 
demand, without requiring any significant additional equity investment (Year 7). 
 
3.10.1. Breakeven analysis 
The business will be profitable by year 5, showing a working capital of R16 418 459, and a 
retained income of R1 992 059. 
Although there is evidence of profit for the above scenarios, the amount of product 
produced, based on these models suggests that only 10 % of RCL chickens can be 
serviced.  
 
3.11. CONCLUSION 
Based on the above economic feasibility study, there is a space in the market for ε-PL use 
as a food preservative in South Africa. The main area of concern is the low production 
volumes to cater for the very large chicken industry in South Africa. For this main reason, 
metabolic engineering could be employed in order to increase yields.  
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CHAPTER 4. METABOLIC ENGINEERING 
 
4.1. INTRODUCTION 
ε-PL is a natural secondary metabolite produced naturally by S. albulus, a Gram positive, 
aerobic,  filamentous bacteria found in the soil.  It consists of 25-35 L-lysine residues, 
characterized by a peptide bond between the α-carboxyl and ε-amino group (Shima and 
Sakai, 1984). ε-PL has attracted significant attention due to its wide antimicrobial 
spectrum and high safety allowing its use as a food preservative in Japan and Korea 
(Hiraki et al., 2003). Based on this, there is a need for improvement of ε-PL production to 
meet the demand. 
Strain improvement strategies have included various culture optimisation attempts to 
enhance ε-PL production.  Although these have shown improvement of ε-PL yield, the 
medium cost contributes a very high percentage of overall production costs, more 
specifically, 40-60% of cost (Demain, 2006). As an alternative option, metabolic 
engineering can be used for strain improvement.  
Metabolic engineering can been described as the “improvement of cellular activities by the 
manipulation of enzymatic, transport and regulatory functions of the cell with use of 
recombinant DNA technology” (Bailey, 1991). There may be several different motives for 
the metabolic engineering of microorganisms which can include:  extension of the 
substrate range of a product; removal or reduction of by-product formation; introduction of 
innovative pathways for product production and improvement of yield and productivity of 
commercially valuable products (Kern et al., 2007). 
There has been limited metabolic engineering work on S. albulus to improve ε-PL 
production. In a previous study in our laboratory, there was an attempt to clone the 
glycerol operon, which contains three genes (glpD, glpF and glpK), from E. coli 
(Weissenborn et al., 1992).  This is because E. coli shows very efficient glycerol 
metabolism and the operon could subsequently enhance the glycerol utilisation in S. 
albulus. The study however only showed successful cloning of the glpD which did not 
amount to improved ε-PL production (Unpublished data) 
Another study used the fact that, L-lysine molecule is utilised to produce ε- PL and is 
biosynthesized by the aspartate pathway. The first two enzymes in the pathway are 
aspartokinase (Ask) and aspartate semialdehyde dehydrogenase (Asd) (Appendix 7.5). 
Ask is responsible for catalysing the phosphorylation L-aspartic acid to L-4-phospho 
58 
 
aspartic acid. These enzymes are highly regulated and different bacteria have different 
patterns of their regulation. Many of the Ask genes in different bacteria are susceptible to 
feedback inhibitions. S. albulus, Ask was found to be partially resistant to feedback-
inhibition.  A mutant, rAsk (M68V) was created whose feedback inhibition regulation was 
completely removed. The results showed that the rAsk produced a maximum of 15 g/L of 
ε- PL as opposed to 11g/L in the wild type (Hamano et al, 2007). 
Lastly, the effects of precursor engineering, whereby addition of external L-lysine on ε-PL 
production was evaluated in Streptomyces sp. M-Z18.  In combination with glucose–
glycerol co-fermentation ε-PL production, was shown to be 37.6 g/L, which was 6.2 % 
greater than without L-lysine (35.14 g/L) (Chen et al., 2013).  
 
Due to this limited work done both in our laboratory as well as abroad, there is a space in 
order to pioneer metabolic engineering in S. albulus. However, modern day tools have not 
been developed for such experiments in S. albulus. Currently, two efficient engineering 
methods have been used to create mutations in bacteria. The first, makes use of group II 
introns to perform gene knockouts in bacteria. This method has been successful in a wide 
variety of bacteria but has not been developed for Streptomyces (Karberg et al., 2001). 
The second, λ-red recombineering has been a well-developed technique for knocking out 
gene in E. coli.  This method can be used to perform several knockouts in one week and 
has been successful in S. coelicolor, although the method is both time consuming and 
laborious (Gust et al., 2004) 
The rationale of this chapter is to develop tools and protocols for metabolic engineering of 
S. albulus CCRC 11814 in order to increase the metabolic flux, growth and ε-PL 
production. More specifically, it aims to optimise two different techniques, namely group II 
introns and recombineering.  To our knowledge, this is the first experiment of its kind in S. 
albulus.  
 
4.2. MATERIALS AND METHODS 
4.2.1. Bacterial strains, plasmids, and media 
The S. albulus, E. coli strains and plasmids used in this study are listed in Table 4.1 
below.  
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Strain or plasmid 
Relevant characteristics 
and uses Reference or source 
S. albulus strains     
  CCRC 11814  
Containing cryptic plasmid 
pNO33 
Provided from the University 
of Japan 
  CCRC 11814* Cryptic plasmid (pNO33) free This study 
E. coli strains     
  DH5α For cloning experiments 
 
  BW25113 
Contains plasmid for 
recombineering 
A gift from Prof Bertolt Gust 
(Department of 
Pharmaceutical Biology – 
Tübingen University) 
Plasmids     
  pLAE001 Transformation experiments 
 
  pKD20 Genes for recombineering A gift from Prof Bertolt Gust 
  pACD4K-C 
(linear) Group II introns Targetron System (Sigma) 
  pACD4K-C 
(circular) Plasmid design This study 
  pIJ12551 Source of ermE* promoter 
A gift from Prof Mervyn Bibb 
(John Innes Centre, Norwich) 
* Plasmid was removed from the strain through the creation of protoplasts.  
 
4.2.2. Gene Knockout - λ-Red mediated recombineering 
The current recombineering procedure to perform gene knockouts in S. coelicolor is 
laborious and time consuming. In an attempt to reduce the complexity around this method, 
the recombineering proteins were isolated from the plasmid pIJ790 for use in gene 
knockouts.  
 
Protein expression and isolation 
E. coli BW2511 containing pIJ790 was first grown in LB (Appendix 7.1) as a 5 mL 
preculture followed by growth in 50 mL flasks in the presence of L-arabinose (Sigma-
Aldrich) of varying concentrations (10%, 1%, 0.1%, 0.01% and 0.001%).  
L-arabinose was used to induce expression of the paraBAD promoter (3 hours), which 
expresses the three genes. The cells were then centrifuged (Sorvall RC 6+TM centrifuge) 
at 5000 x g for 10 min and the supernatant was discarded. The cells were resuspended in 
5 mL of protein lysis buffer (Appendix 7.1) and sonicated in order to disrupt the cell 
Table 4.1. The strains and plasmids used and their relevant characteristics to 
the study. 
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membrane (five times for 15 s).  The mixture was then centrifuged (16 000 x g for 20 min) 
using a F15-8x50C Sorvall RC 6+TM centrifuge in order to bring all the cell debris to the 
bottom and the protein (if soluble) would be found in the supernatant. The proteins were 
then quantified using the Qubit® 2.0 Fluorometer (Life TechnologiesTM) 1. The supernatant 
samples were then run on a 12% SDS gel and viewed using the ChemiDocTM MP Imaging 
System (Biorad).  
 
4.2.3. Gene Knockout - Group II introns 
The group II intron technique was initially performed using the TargeTron® Gene 
Knockout System (Sigma-Aldrich). Several steps are involved in this system which 
included: target site selection and primer ordering, primer preparation and PCR, gel 
electrophoresis, PCR product clean-up, restriction digest and purification, ligation, 
transformation and blue-white colony selection. Each of these steps is described in more 
detail below. In order to establish these techniques in our laboratory, the pld gene of S. 
albulus was selected (described in section 1.3.5).  
 
Target site selection and primer ordering 
The sequence of the pld gene (accession no. AB243405) of S. albulus was downloaded 
from GenBank and used in designing primers for retargeting the group II intron with the 
aid of the TargeTron Design Site software (www.sigmaaldrich.com/targetron). The primers 
were designed based on a specific algorithm which searches for potential LtrA recognition 
sites within a sequence, and then provides the sequence of the appropriate 
oligonucleotides to retarget Ll.LtrB. The primer sets (IBS, EBS2, and EBS1d) were 
ordered from Inqaba Biotech, South Africa. The primer sequences are shown in Table 4.2.  
 
 
_______________________________________________________________________ 
1 The Qubit® 2.0 Fluorometer functions through the use of Molecular Probes® dyes to quantify 
biomolecules of interest. The fluorescent dyes will only emit signals when they are bound to 
specific target molecules, even at low concentrations. The Qubit® 2.0 Fluorometer was used as 
opposed to the nanodrop because it has been shown to be more accurate (The Qubit® 2.0 
Fluorometer user guide, 2012). 
 
61 
 
 
 
 
 
 
 
 
 
Primer preparation and PCR  
The stock solutions of the IBS and EBS1d primers were used (100 μM), and the EBS2 
primer was diluted to 20 μM, in nuclease free water. These three primers were mixed, with 
the fourth universal primer, EBS universal primer, to prepare a mix for overlapping PCR 
(Table 4.3). A PCR was performed using a PCR mix shown in Table 4.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Primer Sequence (5' to 3' direction) Size
PCR product 
size (bp)
IBS AAAAAAGCTTATAATTATCCTTACCACCCCACCGCGTGCGCCCAGATAGGGTG 53
EBS1d CAGATTGTACAAATGTGGTGATAACAGATAAGTCCACCGCGGTAACTTACCTTTCTTTGT 60
EBS2 TGAACGCAAGTTTCTAATTTCGGTTGGTGGTCGATAGAGGAAAGTGTCT 49
EBS 
Universal
CGAAATTAGAAACTTGCGTTCAGTAAAC 28
350
Table 4.2. The primer sequences used to retarget the intron region for gene 
knockout 
Reagent Volume (µL) Concentration (µM)
IBS Primer 2 100
EBS1d Primer 2 100
EBS2 Primer 2 20
EBS Universal 
Primer
2 20
Nuclease free 
water
12
Total Volume 20
Table 4.3. Four primer master mix for use in the PCR reaction 
Reagent Volume (µL) Concentration (µM)
Nuclease free water 23
Four Primer Mix (Gene specific 
or LacZ positive control)
1
Intron PCR template 1
JumpStart REDTaq ReadyMix 25 2.5 units/reaction
Total Volume 50
Table 4.4. PCR mix used for the re-targeting of the intron 
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The PCR was performed using the T100TM Thermocycler (Biorad) with the conditions 
shown in Table 4.5.  
 
 
 
 
 
 
 
 
 
The primers orientation to retarget the intron in the PCR are shown in Figure 4.1.  
 
 
 
 
 
 
Gel Electrophoresis 
A 3% agarose gel (Bioline) (Appendix 7.1) was used to visualize if the correctly sized 
fragment was amplified during PCR and to check for spurious amplification. The PCR 
product sizes were determined using a GeneRulerTM 1kb Plus DNA Ladder (Fermentas). 
Ethidium bromide (10 μg/ml) (Bioline) was added to the gel during preparation. This 
chemical intercalates between the DNA nucleotides and when exposed to UV light, 
fluoresces, thus allowing the DNA to be visualized. The gel was visualized using the 
ChemiDocTM MP Imaging System (Biorad). 
 
 
 
Step Temperature (°C) Time (seconds) No. of cycles
Initial Denaturation 94 30 1
Denaturation 94 15
Annealing Gradient (52-65) 30
Extension 72 30
Final Extension 72 120 1
Hold 4 ∞
30
Table 4.5. PCR conditions for the re-targeting of the intron 
Figure 4.1. Primer orientation for intron retargeting in PCR. (TargeTron® Gene 
Knockout System user manual, 2013). 
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PCR product clean-up 
Following successful PCR amplification, products were confirmed and cleaned using a 
NucleoSpin ® Extract II Cleanup kit (Macherey-Nagel, Clontech Laboratories, Inc). This kit 
removes the excess primers and other contaminants, such as salts, from the PCR 
reaction mix to prevent them from interfering in the downstream applications of ligation 
and transformation. This clean-up involves the use of a column and is a three step 
process. Firstly, the DNA binds to the column and is trapped on it. The remaining 
contaminants are eluted through several wash steps. Elution buffer is then used to elute 
the DNA from the column (NucleoSpin ® Extract II Cleanup kit manual). The protocol 
followed is given in Appendix 7.2. 
 
Restriction Digest and purification 
A restriction digest was performed on the PCR product in order to create sticky end to 
allow for the ligation into the vector. A double digestion was performed using the 
restriction enzymes Hind III and BsrG I. Hind III recognizes a 6 bp site AAGCTT/TTCGAA 
and the cleavage of this sequence between the AA's results in 5' overhangs producing 
sticky ends. BsrG I recognizes a 6 bp site TGTACA/ACATGT and also creates sticky 
ends. The setup for the restriction digest is shown in Table 4.6.  
 
 
 
 
 
 
 
Reagents used in this setup were provided in the TargeTron® gene knockout system (Sigma-
Aldrich). 
 
The restriction products were purified using the NucleoSpin ® Extract II Cleanup kit 
(Macherey-Nagel, Clontech Laboratories, Inc) in order to remove excess restriction 
enzymes and small DNA fragments.  
 
Reagent Volume (µl) Concentration
Purified PCR product 8 ~ 200 ng
10x Restriction Enzyme Buffer 2 10x
Hind III 1 20 U/µl
BsrG I 1 10 U/µl
Nucelase free water 8
Total volume 20
Table 4.6. Restriction digest setup 
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Ligation 
The restricted intron PCR product was ligated into a pACD4K-c. The ratio of insert to 
vector was 3:1 in order to allow for an optimum ligation reaction. The reaction mixture for 
the ligation setup is outlined in Table 4.7 below.  
 
 
 
 
 
 
 
pACD4K-c linear vector was provided in the TargeTron® gene knockout system (Sigma-Aldrich). 
T4 DNA ligase buffer and T4 DNA ligase were obtained from Thermo Scientific.  
 
Transformation and blue-white colony selection 
Competent E. coli DH5α cells were transformed with the pACD4K-c vector containing the 
restricted intron PCR product. The cells were made competent using the detailed 
procedure outlined in Appendix 7.4.  In summary, the cells and ligation reaction were kept 
on ice followed by a brief heat shocking step and the addition of SOC media. Lastly, the 
cells were incubated on a rotary shaker (Labcon) at 220 rpm and 37°C. 100 µl of the 
reaction was spread onto LB agar plates containing chloramphenicol (25 mg/ml) (Sigma-
Aldrich), IPTG (100 mM) (Sigma-Aldrich) and X-Gal (20 mg/mL) (Sigma-Aldrich). The 
plates were incubated at 37°C overnight, after which blue-white colony selection was used 
in order to identify recombinant cells. Colony PCR was used to confirm the presence of 
the insert.  
 
Plasmid isolation 
The pACD4K-c plasmid containing the insert was purified using the Nucleospin® Plasmid 
QuickPure (Macherey-Nagel, Clontech Laboratories, Inc). The detailed procedure is 
outlined in Appendix 7.3.  
Reagent Volume (µl) Concentration
pACD4K-C linear vector 2 40ng
Restriction digest intron PCR product 6 350bp
T4 DNA ligase buffer 2 10X
T4 DNA ligase 1
Nuclease free water 9
Total volume 20
Table 4.7. The reaction mixture for the ligation setup 
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The vector however was not able to be stably transformed into S. albulus because it does 
not contain the correct replicon and promoter and therefore a construct was required to be 
designed. 
 
Construct design 
Through the above described steps it was founded that a novel shuttle vector (construct) 
would need to be designed in order to complete a gene knockout using the group II intron 
method. This construct was designed using three plasmids: pLAE001, pACD4K-C and 
pIJ12551. Several portions of each of the plasmids were required in order to make a 
functional shuttle vector between S. albulus and E. coli (Table 4.8).  
 
 
Plasmid 
Section 
required Size  Function 
pIJ12551 
ermE* 
promoter 82 bp Expression 
pLAE001 pNO33 replicon 4.1 kb 
Successful replication in S. albulus and 
E. coli 
 
bla 861 bp For selection in S. albulus (tsr) and E. coli 
(tsr) 
  tsr 421 bp 
pACD4K-
c 
Intron RNA 
region 2.3 kb Functional expression of the group II 
intron RNP 
 
LtrA ORF 2 kb 
pVBKR                                       ~8.6 kb 
 
In order to transfer the functional components of the TargeTron system to an alternative 
vector backbone, sub-clone the sequence from the promoter region to the end of the LtrA 
ORF (~4.5 kb). This region contains all the required features for functional expression of 
the group II intron RNP. Sub-cloning of the region may be performed by PCR amplification 
or restriction digestion. 
The plasmid maps used for the construct were derived using VectorNTI Advance 10. All 
plasmid maps used for pVBKR construction are shown in Appendix 7.6. 
The first step to plasmid construction was to join the ermE* promoter (82 bp) (from 
pIJ12551) to a portion of the pACD4K-C (from 1802 bp to 6161 bp = ~ 4.3 kb). This was 
Table 4.8. Plasmid regions and functions required for pVBKR construction 
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performed using overlap extension PCR. An intial PCR was performed in order to amplify 
the 4.3 kb region of pACD4K-c plasmid using the pACD4K-c F and R primers. The 
pACD4K-c vector was first linearised by ligating the two blunt ends. A second PCR was 
performed in order to amplify the promoter ermE*. The two PCR products were then 
joined together using overlap extension PCR. The primer sequences used are shown in 
Table 4.9.  
 
 
 
 
 
 
 
 
 
 
 
In order to splice two DNA molecules, special primers were used at the ends of the pieces 
that are to be joined. For each molecule, the primer at the end to be joined is constructed 
so that the 5' overhang complementary to the end of the other molecule (Figure 4.2). 
Once both DNA molecules are extended in such a manner, they are mixed and a PCR is 
carried out with only the primers for the far ends. The overlapping complementary 
sequences introduced will serve as primers and the two sequences will be fused (Bryksin 
and Matsumura, 2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Name Primer Sequence (5' to 3' direction) Size
pIJ12551 - F GACCCGAGCACGCGCCGGCA 20
pIJ12551 - R TATTTTGCATCGCATGGACGTCCCCTTC 28
pACD4K-c - F TCCATGCGATGCAAAATAACGGCGCTGCT 29
pACD4K-c - R AGCTTATCATCGATAAGCT 19
Table 4.9. The primer sequences used to amplify the ermE* promoter and 
pACD4K-c for plasmid construction. 
Figure 4.2. Overlap extension PCR process (Reproduced from Bryksin and 
Matsumura, 2010).   
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4.2.4. Introduction of DNA into S. albulus 
The plasmid pLAE001 was used for insertion into S. albulus for the below described 
experiments and was designed as a shuttle vector between S. albulus and E. coli 
(Hamano et al., 2005).  
 
Chemical transformation 
In order to introduce a plasmid into S. albulus, protoplast transformation of cells was 
performed in order to cure the strain of the cryptic plasmid pNO33 which is found naturally 
in the bacteria. This is because pNO33 and pLAE001 have the same replicon and if both 
plasmids are inserted into the bacteria there would be an incompatibility problem causing 
one of the plasmids to be ‘knocked out’.  
In order to generate protoplasts, a 4 mL preculture of LB media (Appendix 7.1) was 
placed into a 50 mL Erlenmeyer flask containing 10 glass beads and inoculated with a 
single S. albulus colony from a fresh LB agar streak plate containing glucose (2 %). This 
was incubated at 30°C for 48 hours. 0.5 mL of the preculture was transferred to a 250 mL 
Erlenmeyer flask containing 50 mL LB and 2 % glycine. The cells were then centrifuged at 
1500 x g for 10 minutes in 50 mL falcon tubes. The supernatant was removed and 10 mL 
of Protoplast (P) buffer (Appendix 7.1) was added to the cells in order to wash them by 
centrifugation at 1500 x g for 10 minutes. The supernatant was removed and the cells 
were resuspended in 10 mL of P Buffer again at 1500 x g for 10 minutes. 30 mL of P 
buffer containing 5 mg/mL of lysozyme was added to the cells and they were incubated at 
30°C for 3 hours. During this incubation the tubes were inverted every 10 – 20 minutes.  
After the incubation, 10 mL of cold P buffer was added after the incubation and cells were 
harvested by centrifugation followed by two washes with 10 ml P buffer (cells were 
resuspended between each wash). Finally, protoplasts were resuspended in 2 mL P 
buffer and 500 µl aliquots were stored at -70°C. 
Protoplasts were then regenerated on a Rhodococcus regeneration media previously 
described by Dabbs et al., 1990 (Appendix 6.1). A 100 µl suspension of the protoplasts 
were spread onto the regeneration media and allowed to grow for 24 hours at 25°C. 
Isolated colonies were placed in 10 µl LB broth and used as a DNA source in a colony 
PCR. The primers used for this PCR were designed to bind to the replicon region of 
pNO33 (Table 4.10). Colonies showing no amplicon and therefore the loss of the plasmid 
were selected. 
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These were then used to culture an S. albulus strain which is missing the pNO33 plasmid. 
The pLAE001 plasmid was then inserted into the strain by thawing protoplasts and 
transferring 100 µl into an Eppendorf to which 5 µl of plasmid was added (100 ng/µl). The 
contents were mixed and the tube was placed on ice for 1 minute followed by the addition 
of 400 µl of P buffer. 100 µl of the mixture was then spread on Rhodococcus regeneration 
media. The plates were sealed with parafilm and incubated at 30°C for 24 hours. The 
following day, 3.5 ML of soft nutrient agar overlay was added containing thiostrepton  
(5 µg/mL) (Sigma-Aldrich). The plates were sealed with parafilm and incubated for a 
further 5 days at 30°C. 
 
Electroporation 
Electroporation involves the application of a short, high voltage to cells which creates 
transient pores in the membrane which facilitates the uptake of DNA (Pigac and 
Schrempf, 2005). Electroporation was performed using the ECM® 830 Electroporation 
System (BTX Harvard Apparatus) following the protocol outlined below (Figure 4.3). The 
electroporation cuvette used was a 2 mm Gene Pulser® Cuvette (Biorad). 
 
 
 
 
 
 
 
 
Table 4.10. The primer sequences used to identify the loss of the pNO33 plasmid. 
 Name Primer Sequence (5' to 3' direction) Size
PCR product 
size (bp)
pNO33 - F CTGTACACGCGAACTGTCGT 20
pNO33 - R TTTTGTGGCATGATCCTTGA 20
600
Figure 4.3. A summarised electroporation procedure for Streptomyces bacteria. The 
basic procedure of electroporation in Streptomyces requires freshly harvested spores 
which are heat shocked and chilled on ice. The DNA (plasmid) is added and the mixture is 
electroshocked. The cells are then grown on an agar plate and colonies are screened for 
the presence of the plasmid. 
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Reagent Volume (µL) Concentration (µM)
Dream Taq Green PCR Master 
Mix 
10 1 x
Forward Primer 0.5 10
Reverse Primer 0.5 10
Template DNA 2
Nuclease free water 7
Total Volume 20
Optimization of electroporation parameters were required because to our knowledge,  
electroporation has never been attempted in S. albulus. The different parameters 
attempted are shown in the Table 4.11 below: 
 
 
 
 
 
 
 
 
 
The different attempts to perform electroporation for S. albulus using different parameters in terms 
of voltage, pulse number and length and intervals between pulses.  
 
Confirmation of gene transfer techniques 
Transformation and regeneration efficiencies were calculated for both gene transfer 
methods. Regeneration efficiency was calculated by dividing the number of regenerated 
colonies by the original number of cells used in the transformation (Katsumata et al., 
1984). In order to confirm if the bacteria contained the pLAE001 plasmid, a single colony 
from the regeneration media/NA overlay was selected. This single colony was 
resuspended in 10 µl of LB and was used as the template DNA in a PCR setup as shown 
in the Table 4.12 below. 
 
 
 
 
 
 
 
 
Parameter Attempt 1 Attempt 2 Attempt 3 
Mode High Voltage High Voltage High Voltage 
Voltage 2500 V 2500 V 2000 V 
Pulse Length 100 120 100 
No. of pulses 1 2 2 
Interval 100 120 100 
Polarity Unipolar Unipolar Unipolar 
Table 4.11. The different parameters attempted for electroporation of S. albulus 
bacteria 
 
Table 4.12. PCR mix used for the confirmation of pLAE001 transfer to  
S. albulus. 
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4.3. RESULTS 
In order to improve ε-PL production while using economically viable crude glycerol, two 
engineering strategies were attempted, recombineering and group II introns.  
 
4.3.1. Recombineering – Protein expression 
The first method, recombineering make use of three phage proteins and has been 
successfully used in E. coli. This process has been transferred to a member of the 
Streptomyces species, S. coelicolor; however it is lengthy, laborious and costly. For these 
reasons, a more simplified method was attempted by expressing these proteins in vitro.  
The SDS page gel shown in Figure 4.4 shows an attempt to express the three phage 
proteins from the pIJ790 plasmid using different concentrations of L-arabinose. There was 
no difference between induced (lanes 2-6) and non-induced (lane 7) E. coli cells 
containing the pIJ790 plasmid.  
 
 
 
 
 
 
 
 
 
 
 
 
The simplification of the recombineering method was shown to be unsuccessful as shown 
by the inability to express the proteins in vitro. The recombineering method was not 
attempted further and a different engineering method, namely group II introns was 
studied.  
Figure 4.4. An SDS-Page for the extraction of three recombineering proteins: 
gamma, beta and exo from E. coli BW25113 containing the pIJ790 plasmid induced 
with different concentrations of L-arabinose.  (1) Page RulerTM Plus Prestained 
Protein Ladder (Fermentas); (2) 10 % L-arabinose; (3) 1 % L-arabinose; (4) 0.1 % L-
arabinose; (5) 0.01 % L-arabinose; (6) 0.001 % L-arabinose (7) Un-induced. The red 
rectangles represent the proteins of interest of 28 kDa; 24 kDa and 16 kDa going down, 
respectively. 
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4.3.2. Group II introns 
The group II intron method was attempted using the TargeTron® gene knockout kit from 
Sigma Aldrich.  
 
Gel electrophoresis for viewing PCR products 
The first step involves a PCR using specific primers in order to retarget the intron to the 
target DNA. The results show the experiment as well as both positive and negative 
control. The gel produces three distinct bands (Figure 4.5). The uppermost 350 bp band is 
the desired and more prominent band at suitable temperatures (lanes 6-9). Even though 
the lower two bands are visible, they do not affect downstream applications significantly 
and therefore do not need to be removed by agarose gel purification (TargeTron® Gene 
Knockout System).The optimal temperature for the PCR products was found to be 
between 52°C and 55°C corresponding to lanes 6-9.  
 
 
 
 
 
 
 
 
 
 
Transformation and blue-white colony screening 
The next steps involve the ligation of the PCR product into a linearized pACD4K-c vector 
that contains the remaining intron components. The ligation reaction is then transformed 
into a host organism followed by expression of the re-targeted intron.  
The PCR product which was ligated into the linear pACD4K-c vector was transformed into 
competent E. coli DH5α cells and grown on LB plates (Figure 4.6). The experiment and 
positive control plates (Figure 4.6 A and B), both showed the presence of blue and white 
350 
bp 
Figure 4.5. PCR for intron re-targeting of the pld gene on a 4% agarose gel. The first 
lane shows the 1 kb+ DNA ladder. Lanes 1-9 shows the different temperatures of the 
experiment ranging from 65°C in lane 1 to 52°C in lane 9. Lane 10 shows the positive 
control of the LacZ gene knockout. Lane 11 and 12 show the negative control (random 
DNA template) and non-template control respectively. 
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colonies. The plate containing the vector (Figure 4.6 C), only showed blue colonies, while 
plates containing only the insert or neither the vector or the insert (Figure 4.6 D and E 
respectively).  
 
 
 
 
 
 
 
 
 
 
 
 
 
The recombinant plasmid obtained from the above (Figure 4.6), was not transformed into 
S. albulus successfully, as it does not have the correct replicon. For these reasons, a new 
plasmid was constructed in order to create gene knockouts in S. albulus. 
 
In silico plasmid construction 
An in silico construct model was designed using SnapGene Viewer Version 2.2.1 and is 
shown in Figure 4.7. This plasmid contains all required components in order to use group 
II introns for gene knockouts in S. albulus. The ermE* promoter (yellow) is required for 
constitutive gene expression of the intron RNA (purple - including the 3’ exon) which is 
required to perform gene knockouts using group II introns. The LtrA ORF (green) contains 
the genes for catalytic and mobile activity of the intron. The replicon (dark blue) is required 
for plasmid replication in both E. coli and S. albulus. The resistance genes: AmpR (light 
blue) and thiostrepton (red) to allow for selection in E. coli and S. albulus, respectively. 
 
 
A B C 
D E 
Figure 4.6. Blue-white colony selection plates.  (a) Experiment plate (Pld gene 
knockout) containing IPTG, X-GAL and Amp with both blue and white colonies present.  
(b) Positive control plate (LacZ gene knockout) plate containing IPTG, X-GAL and Amp 
with both blue and white colonies present.  (c) Vector only containing IPTG, X-GAL and 
Amp with only blue colonies present. (d) Insert only containing IPTG, X-GAL and Amp 
with no colonies present. (e) Plate containing competent cells only. 
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In order to construct the plasmid, the amplification of several of the required regions was 
performed with specially designed primers to ultimately perform an overlap PCR. The 
ermE* promoter was successfully amplified from the pIJ12551 plasmid. The 4% agarose 
gel below shows successful amplification of the ermE* promoter which is 82 bp  
(Figure 4.8) 
 
 
 
 
 
 
 
 
 
Figure 4.7. An in silico design of the pVBKR plasmid. The plasmid shows the 
necessary regions required to perform gene knockout experiments. The ermE* 
promoter (yellow) is required for constitutive gene expression of the intron RNA (purple 
- including the 3’ exon) which is required to perform gene knockouts using group II 
introns. The LtrA ORF (green) is responsible for the catalytic and retrohoming activity of 
the intron . The replicon (dark blue) is required for plasmid replication in both E. coli and 
S. albulus. The resistance genes: AmpR (light blue) and thiostrepton (red) to allow for 
selection in E. coli and S. albulus, respectively. 
Figure 4.8. A 4% agarose gel showing the successful amplification of the 
ermE* promoter. (1) GeneRulerTM 1kb Plus DNA Ladder (Fermentas). (2) ermE* 
concentration 1. (3) ermE* concentration 2. (4) NTC.  
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Secondly, the intron RNA region as well as the LtrA region required for the gene knockout 
from the circular pACD4K-c plasmid.  The 1% agarose gel below shows successful 
amplification of the pACD4K-c region which is ~4500 bp (Figure 4.9) 
 
 
 
 
 
 
 
  
 
Lastly, the replicon region required for stable transformation into E. coli and Streptomyces 
was PCR amplified from the pLAE001 plasmid. The 1% agarose gel below shows 
successful amplification of the amplicon is ~4100 bp (Figure 4.10) 
 
 
 
 
 
 
 
 
 
4.3.3. Introduction of genetic material 
Once a gene knockout has been successful on a plasmid which is in E. coli, it must be 
transferred to S. albulus. This can be performed by either chemical or physical 
~ 4500 bp 
Figure 4.9. A 1% agarose gel showing the successful amplification of the ~ 4.5 kb 
region on the pACD4K-c plasmid. (1) GeneRulerTM 1kb DNA Ladder (Fermentas). (2) 
NTC. (3-12) pACD4K-c region amplification replicates. 
~ 4100 bp 
Figure 4.10. A 1% agarose gel showing the successful amplification of the 
replicon. (1) GeneRulerTM 1kb Plus DNA Ladder (Fermentas). (2) 4.1 kb replicon region. 
(3) NTC.  
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transformation. The prior requires the formation of protoplast in order to ease the process 
by removing the bacterial cell wall as well as removing the cryptic plasmid pNO33 found in 
S. albulus. 
Protoplasts were made and observed under a compound microscope and compared with 
normal S. albulus in order to confirm successful protoplast creation. According to the 
images, protoplasts were made under optimal conditions of growing the cells at 30 °C for 
48 hours (Figure 4.11).  
 
 
 
 
 
 
 
 
 
 
 
A colony PCR was performed on regenerated protoplasts in order to select for those 
which had lost their pNO33 plasmid. Primers were designed to amplify a ~650 bp region 
on the replicon. The presence of a band indicates the presence of a pNO33 plasmid and 
the absence shows the loss of the pNO33 plasmid. A total of 5 bands were visible on the 
gel showing the presence of the pNO33 plasmid, while the remainder showed no band 
(Figure 4.12).  
 
 
 
 
A B 
10 μM 15 μM 
 
Figure 4.11. S. albulus cells and protoplasts under a compound microscope. (a) 
The filamentous structure of S. albulus. (b) Protoplasts which have lost their filamentous 
shape and appear circular shaped (shown in red) amongst the cell debris. 400 X 
magnification. 
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S. albulus cells that had lost their pNO33 were then transformed with pLAE001 extracted 
from E. coli DH5α using protoplasts and their growth on the regeneration media. The 
transformation efficiency was at its highest level when the mycelia were grown for 24 h at 
30°C on a rotary shaker at 220 rpm. 
 
4.3.3.1. pLAE001 introduction into S. albulus via chemical transformation 
The pLAE001 plasmid was introduced into S. albulus via chemical transformation and the 
cells were then grown on media containing the selective marker. Chemical transformation 
showed many colonies on the Rhodococcus regeneration media containing a soft nutrient 
overlay as shown in Figure 4.13 below, after a total of 6 days at 25°C.   
 
 
 
 
 
 
 
Figure 4.13. Growth of S. albulus on Rhodococcus regeneration media 
containing a soft nutrient overlay after transformation. The conditions for growth 
were 25°C for a total of 6 days. Growth can be seen throughout the entire plate.  
Figure 4.12. Detection of the cryptic plasmid pNO33 in S. albulus regenerated 
protoplasts. (1kb+) GeneRulerTM 1kb Plus DNA Ladder (Fermentas); (1-12) Different 
colonies on Rhodococcus media tested for the presence of the pNO33 plasmid; (13) 
pNO33 plasmid; (14-24) Different colonies on Rhodococcus media tested for the 
presence of the pNO33 plasmid; (25) NTC; (26) pNO33 plasmid. The arrows show the 
presence of a band indicating the presence of the pNO33 plasmid. 
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Nine colonies were selected to test for the presence of the pLAE001 plasmid. The nine 
colonies showed the presence of a ~ 650 bp band after colony PCR (Figure 4.14). This 
shows the success of the chemical transformation of S. albulus with the pLAE001 
plasmid.  
 
 
 
 
 
 
 
 
 
4.3.3.2. pLAE001 introduction after electroporation 
The pLAE001 plasmid was introduced into S. albulus via physical transformation and 
grown on selective media. Electroporation showed few colonies on the Rhodococcus 
regeneration media containing a soft nutrient overlay as shown in Figure 4.15 below, after 
a total of 7 days at 25°C.   
 
 
 
 
 
 
 
 
 
Figure 4.15. Growth of S. albulus on Rhodococcus regeneration media containing 
a soft nutrient overlay after electroporation. There are several colonies visible on the 
plate indicated by the red circle. The conditions for growth were 25°C for a total of 7 
days.  
Figure 4.14. A 1% agarose gel showing the successful amplification of a portion 
pLAE001 from S. albulus. (1) GeneRulerTM 1kb Plus DNA Ladder (Fermentas). (2-9) 
pLAE001 region amplification replicates. (10) pLAE001 plasmid. (11) NTC. The nine 
selected colonies showed the successful amplification of a region of the pLAE001 
plasmid.  
~650 bp 
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After electroporation, 12 colonies were selected for a colony PCR, which showed no 
amplification of a portion of the pLAE001 plasmid. There were no transformants 
containing the plasmid found using all the parameters tested as well as different protocols 
for creating electrocompetent cells (Figure 4.16).  
 
 
 
 
 
 
 
 
 
The two procedures were then compared in order to determine the most optimal one to 
use for further applications. Transformation is a longer procedure as compared with 
electroporation; however it yielded a larger amount of transformants.  In addition the 
regeneration efficiency of transformation, 62 % was higher as compared with 
electroporation, 2.3 %. Comparison of the two gene transfer techniques is shown in Table 
4.13.  
      
The table compares two gene transfer methods in S. albulus in terms of the regeneration efficiency, 
which was higher with the use of chemical transformation (62 %) as compared with electroporation 
(2.3 %). Transformation efficiency was also higher using chemical transformation, 7.75 ± 3.2 
transformants/µg, as opposed to 3.77 x 10
-1
 ± 1.1 transformants/µg with electroporation. Lastly, the 
time required which is longer using chemical transformation of 5-7 days and 3 days for 
electroporation.   
Table 4.13. Comparison of two gene transfer methods in S. albulus 
 
Gene Transfer 
Method
Organism
Regeneration 
Effciency (%)
Transformation Efficiency 
(Transformants / μg DNA)
Type of molecule 
delivered
Time 
required
Chemical 
transformation
Bacteria 62 7.75 ± 3.2 Plasmid 5-7 days
Electroporation Bacteria 2.3 3.77 x 10-1 ± 1.1 Plasmid 3 days
Figure 4.16. A 1% agarose gel showing a colony PCR for the confirmation of the 
pLAE001 plasmid after electroporation. (1) GeneRulerTM 1kb Plus DNA Ladder 
(Fermentas); (2-12) pLAE001 region amplification replicates; (13) NTC; (14) pLAE001 
plasmid.  The 11 selected colonies did no show the amplification of a region of the 
pLAE001 plasmid. 
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4.4. DISCUSSION 
The ultimate goal of this project was to improve ε-PL production; this however was not 
possible due to two main reasons: 1. There is very little research done on the metabolic 
pathway of ε-PL production and more specifically on the genes involved in it. In addition, 
the genome was only recently sequenced (Dodd et al., 2013) and during this project the 
sequence was not known. This made it very difficult to identify targets for selection to 
perform metabolic engineering. 2. New, metabolic engineering tools are required to 
quickly and effectively introduce changes into a microorganism and these newer tools 
have not been developed for S. albulus.  
For these reasons, the goal of this project shifted to the development of these tools such 
as group II introns and recombineering for the future of metabolic engineering in S. 
albulus.  
 
Group II introns 
The Targetron® Gene Knockout System was shown to be successful in knocking out 
LacZ in E. coli. This was performed in order to confirm the success of the system.  
In order to use the system in Streptomyces, a plasmid was constructed in order to contain 
all the required components for the gene knockout and subsequent replication and 
maintenance in Streptomyces.  This plasmid could potentially be used in accordance with 
the components originally found in the kit. According to current literature, this is the first 
experiment of its kind.  
Similar experiments have been conducted, using the same principles as shown above.  
The plasmid pNL9164 was constructed for gene knockouts in S. aureus.  Furthermore, the 
pJIR750ai plasmid was designed for gene knockouts in Clostridium perfringens. Both 
these studies showed successful gene knockouts of hsa (Yao et al., 2006) and plc (Chen 
et al., 2005) gene respectively.  
Several concerns may arise through the use of group II introns as a gene knockout 
method. Firstly, group II introns may be used for any DNA sequence, even those found on 
a plasmid. Secondly, there is a concern of polar effects on adjacent genes which could 
reduce the viability of the bacteria. In order to overcome this, the gene of interest should 
be cloned out of the operon and onto a plasmid. Lastly, there is the issue of whether the 
knockout will be stable in subsequent generations. A study was performed in Lactococcus 
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lactis in order to test this. Mutants passaged for 80 generations illustrated that 100% of 
the mutants were stable (Frazier et al., 2003).  
 
For future work, to confirm that all the components of the plasmid have been assembled, it 
should be sequenced.  Following this, the plasmid will be tested to perform a gene 
knockout in S. albulus. The first step would be to select a gene based on transcriptomics 
analysis currently undergoing in our laboratory.  
 
Recombineering 
This experiment was unsuccessful in improving the current laborious recombineering 
method. Based on the study of current literature there is no information on function of the 
Exo, Beta and Gam proteins in vitro. Genes which are placed under the control of the 
arabinose-inducible paraBAD promoter (PBAD) of E. coli are expressed in an “all-or-none 
fashion” (Khlebnikov et al., 2001). The promoter is also referred to as a high level of 
expression promoter of vectors which possess it (Guzman et al., 1995). Even though this 
is the case, there are several possible explanations for the lack of expression. Firstly, the 
plasmid could be a low copy number plasmid. Secondly, the genes are being induced but 
not to a level detectable on a gel because they only function in vivo and are not meant for 
over expression or use in vitro. Lastly, the pBAD promoter may be leaky. There however, 
is no literature to confirm these theories.  
A study by Tyurin, (2013) suggested the use of exogenous recombineering proteins to 
perform gene knockouts and was shown to be successful in Clostridium sp. A similar 
approach can be attempted for use in S. albulus.  Furthermore, a Western blot could be 
used in order to confirm the presence of the proteins; however it was not possible to 
purchase antibodies in time for its completion. Future work could involve the use of a 
different high expression vector or perhaps a different strain of E. coli.  
 
Gene transfer methods 
Protoplast formation is important in Gram positive bacteria, because of the thickness of 
their cell wall, due to the peptidoglycan layer. It is difficult for genetic material to cross this 
layer and therefore the removal of the cell wall can ease this movement. Protoplast 
formation is dependent on the age or physiological state of the mycelium. In some cases 
the older mycelium makes for more successful protoplasts, while in other cases, younger 
mycelium does. This is species dependent (Kieser et al., 2000). High concentrations of 
glycine can cause loss of the cell wall; this effect, at least in some bacteria, is now known 
to be due to replacement of D-alanine residues by glycine in the peptidoglycan, thereby 
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interfering with cross-linking (Hopwood, 1981). Protoplasts were regenerated using 
sucrose, because sugars are known to be good stabilizers for regeneration as they favour 
the osmotic stability for protoplast viability (Ishikawa et al., 2010). 
 
There is debate on which gene transfer technique is best suited to a particular 
microorganism. According to literature, electroporation is less laborious than chemical 
transformation and generally produces higher transformation efficiencies (Hamano et al., 
2005). This however was not the case in this study, whereby the transformation efficiency 
was significantly lower and the obtained colonies did not contain the pLAE001 plasmid. 
There are several explanations for this:  The ECM® 830 Electroporation System was 
mainly but not exclusively designed for mammalian and plant engineering strategies. 
However, this was the only machine available for use during the course of the experiment.  
In addition it is also sensitive to salt, and samples can be lost during the electroporation 
process if traces of salt are detected. This however was minimised due to the elution of 
the plasmid using nuclease free water. Furthermore, electroporation is also expensive in 
terms of the requirement of apparatus and special cuvettes.  
 
Further attempts to improve the electroporation procedure for S. albulus can be performed 
by verifying and optimising physical, biological, and chemical parameters.  
 
Transformation, although a longer method, was shown to be very successful in terms of 
regeneration frequency and transformation efficiency. This coincides with other studies in 
which S. albulus was successfully transformed with a slightly higher transformation 
efficiency of 102  transformants per μg DNA (Hamano et al., 2005).  
 
Apart from chemical transformation and electroporation, conjugation has been of interest 
as it can bypass the need for protoplast formation and regeneration.  In an experiment 
using S. albulus, the conjugation efficiency was very low (exconjugants per recipient 
spores: 9.0x10–8) (Hamano et al., 2005) and therefore also requires optimisation before it 
can be used as a successful method of gene transfer.  
 
Newer engineering techniques 
In a recent study, pls was cloned from strain a newly identified S. albulus strain NK660 by 
genome walking. The pls gene was heterologously expressed in S. lividans ZX7. This 
recombinant strain was shown to synthesise ε-PL. This was the first experiment showing 
heterologous expression of the pls gene in S. lividans. This would allow the possibility of 
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working with a model Streptomyces organism, for which engineering strategies have been 
developed, for improvement of ε-PL production (Geng et al., 2014). 
 
Furthermore, as previously mentioned, the metabolic engineering relates to the concept of 
biocatalysis (Shen and Thorson, 2012). Biocatalysis for industrial biotechnology has 
shown significant growth in the last decade (Bornscheuer, 2012). It is therefore of interest 
to apply biocatalysis to the metabolic engineering of S. albulus to improve ε-PL production 
as previously attempted (section 1.9.2).  One such way is through the use of lipases in 
order to decrease the amounts of salts and methanol from the crude glycerol and 
therefore increase ε-PL yield. Lipases are an attractive alternative to attempt as they have 
been described as the most important group of biocatalysts for biotechnological 
applications (Hasan et al., 2006). Future work can also involve increasing surface 
expression of Pls, by the addition of lysine, which would promote a pure biocatalysis route 
to ε-PL yield improvement. This will allow the use of natural catalysts to improve ε-PL yield 
and therefore make its use as a natural food preservative applicable.  
 
4.5. CONCLUSION 
Metabolic engineering techniques are only applicable with the knowledge of well 
characterized biosynthetic pathways and to organisms for which molecular tools are 
available and optimized to some extent. In addition, an extensive knowledge of the 
biochemistry and physiology of the producing bacteria in order to select appropriate 
metabolic alterations (Paradkar et al., 2003; Li et al., 2013). This however, was not the 
case with S. albulus which could partially account for the difficulty in developing 
techniques. Furthermore, finding a target and increasing ε-PL production in a short period 
was not possible owing to lack of genetic backgrounds (Li et al., 2013). 
 
This study has acted as a stepping stone for research to commence in this field, primarily 
since the recent sequencing of the S. albulus genome. Such research could include the 
study of metabolic flux of both precursors and intermediates and to identify rate limiting 
steps which can act as targets for genetic manipulations. Once the genetic techniques 
have been established potential gene targets for knockout to improve ε-PL production 
should be looked at. 
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CHAPTER 5. FINAL CONCLUSION AND FUTURE WORK 
 
S. albulus has the ability to grow and produce ε-PL in the presence of crude glycerol, 
although at a suboptimal level as compared with glucose and pure glycerol. Due to the 
fact that crude glycerol is not costly, it provides an economically feasible method of 
growing and producing ε-PL for its use as a natural food preservative. However, S. albulus 
grows slowly and the production process is not optimal. Hence, the need to develop tools 
and protocols for metabolic engineering of S. albulus in order to increase ε-PL production. 
Recently, there has been research performed on S. albulus, which will allow for further 
characterisation of genes and proteins. These would be able to create a more detailed 
picture on the metabolome and allow for the improvement of techniques for gene-
knockouts or knock-ins. In addition it will allow for the selection of targets to knock-out/in 
in order to improve glycerol uptake and ε-PL production. 
In general, Streptromyces compared to other microbial production hosts, are not a very 
popular target for metabolic engineering, because they are not as well characterized as 
for example E. coli and therefore requires more elaborate and time consuming 
procedures. With the current rate at which the field of biotechnology and genetic 
engineering is developing, however, the possibility of newer and more efficient techniques 
is not far off.  
 
There has been a large amount of work in the field of biotechnology in terms of secondary 
metabolite improvement during the last decade. Different methods used for genetic and 
metabolic engineering have their advantages and limitations and each may be suited to a 
particular Streptomyces species. The growth potential in the bio-based economy is a 
strong pulling force for bioprocessing and biocatalysis, especially for high-value 
compounds produced by microorganisms such as Streptomyces. This can be employed in 
the case of engineering S. albulus.  
 
This work has laid the foundation for the future of ε-PL production improvement using 
economically viable crude glycerol as a carbon source for potential use of the secondary 
metabolite as a food preservative. 
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7. APPENDICES 
 
7.1. Recipes 
 
Luria Broth (LB) agar (1litre) 
Bacto-tryptone (Merck) 10 g 
Yeast Extract (Merck)   5 g 
Sodium Chloride (Merck)  10 g 
Bacto-agar (Merck)  15 g 
2% glucose (Merck)  7.5g 
 
All components are mixed together and autoclaved (Labotech) for 20min at 121°C.  Once 
cooled slightly, 20ml of LB is poured into 88mm diameter petri dish until solidified. 
 
Luria Broth (LB) medium (1litre) 
Bacto-tryptone (Merck) 10 g 
Yeast Extract (Merck)   5 g 
Sodium Chloride (Merck) 10 g 
2% glucose (Merck)  
 
All components are mixed together and autoclaved for 20min at 121°C. 
 
Defined Media (1 litre) (Rumbold et al., 2009) 
NH4Cl    8 g 
(NH4)2SO4   0.5 g 
MgCl2•6H2O   0.3 g 
EDTA    40 mg 
ZnSO4•7H2O   2 mg 
CaCl2•2H2O   1 mg 
FeSO4•7H2O   15 mg 
Na2MoO4•2H2O  0.2 mg 
CuSO4•5H2O   2 mg 
CoCl2•6H2O   0.4 mg 
MnCl2•4H2O   1 mg 
 
All components are mixed together; the pH is adjusted to pH7.3 using phosphate buffers: 
0.75M K2HPO4 and 0.75M KH2PO4 and the media is purified using sterile syringe 0.45µm 
pore filters. 
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10x PBS (250mL) 
Sodium Chloride (NaCl) 8 g 
Potassium Chloride (KCl) 0.2 g 
Na2HPO4   1.78 g 
KH2PO4   0.24 g 
 
All components are mixed together and autoclaved for 20min at 121°C. 
 
10x TAE (1litre) 
Tris base    48.4 g 
Glacial acetic acid (17.4 M) 11.4 mL 
EDTA, disodium salt  3.7 g 
 
Add up to 1 litre with distilled water and mix all components together.  
 
.1 % Agarose gel 
Add 1 g of agarose (Bioline) to 100 mL 1x TAE. The powder is then melted and cooled 
and 3μl of ethidium bromide (10 μg/ml) (Bioline) is added to the solution. 
 
4% Agarose Gel 
Add 4 g of agarose (Bioline) to 100 mL 1x TAE. The powder is then melted and cooled 
and 3μl of ethidium bromide (10 μg/ml) (Bioline) is added to the solution. 
 
Rhodococcus regeneration media 
35 g of sucrose was dissolved in 280 mL of dH20. After which the following was added: 
Agar   4.5 g 
Tryptone  3 g 
Yeast Extract  1.5 g 
Sodium Chloride  0.9 g 
 
The solution is autoclaved for 20 minutes at 120°C. 
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After autoclaving, the following (filter sterilized – 0.22 µm) was added in this order: 
0.25 M TES  10 mL 
1 M Calcium Chloride 6 mL 
 
 
SOB (1 litre) 
 
2% Peptone 
0.5% Yeast Extract 
10 mM NaCl 
2.5 mM KCl 
10 mM each MgCl2 and MgSO4 
 
 
Pipes buffer 
 
10 mmol/l CaCl2,  
10 mmol/l PIPES-HCl, 
15% glycerol v/v  
 
pH to 7 using sodium hydroxide 
 
Protein lysis buffer 
The following components are mixed together in 1 litre and autoclaved: 
KH2PO4 (the buffer) 6.8 g 
MgCl2.6H2O  0.61 g 
DTT*   0.77 g 
EDTA   0.37 g 
 
*DTT is added after autoclaving in order to prevent its degradation.  
The protein can be stored in the buffer until further use. 
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7.2. Clean up protocols 
7.2.1. NucleoSpin ® Extract II Cleanup (From PCR product, if there are no spurious 
bands)  
 
1. 2 volumes of NT buffer with 1 volume PCR product are mixed (45μl PCR product and 
90μl NT buffer).  
 
2. A column is placed in a collection tube and the sample is loaded onto the column and 
centrifuged for 1 minute at 11 000 g. The flow through is discarded and the column is 
placed back in the collection tube.  
 
3. 600μl of NT3 buffer (to which 70% ethanol is added to before use) is loaded onto the 
column and centrifuged at 1 minute at 11 000 g. The flow through is discarded and the 
column is placed back in the collection tube.  
 
4. The column and collection tube are then dry centrifuged for another 2 minutes at  
11 000 g. The samples are incubated for 2-5 minutes at 70°C to evaporate the ethanol. 
The flow through is discarded and the column is placed in a clean Eppendorf tube.  
 
5. 20μl of elution buffer (at 70°C) is loaded onto the column and the samples are 
incubated for 1 minute at room temperature to increase the yield. The samples are 
centrifuged at 1 minute at 11 000 g. The column is discarded and the cleaned PCR 
product is found in the Eppendorf tube.  
 
7.3. Plasmid Isolation 
1. Bacterial suspension of 3 mL is centrifuged using a benchtop microcentrifuge for 30 s at 
11 000 x g. The supernatant is discarded. 
2. The cells are resuspended in 250 µl of buffer A1 by vortexing. This is followed by the 
addition of 250 µl of buffer A2. The mixture is then inverted 6-8 times and handled with 
care to avoid shearing of genomic DNA. The suspension is then incubated for 5 min at 
room temperature, after which 300 µl of buffer A3 followed by inverting the tube 6-8 times.  
3. The tube is then centrifuged for 5 min at 11,000 x g at room temperature. 
4. A NucleoSpin® Plasmid QuickPure Column is placed in a collection Tube (2 mL) and 
750 µL of the supernatant is pipetted onto it. The tube is centrifuged for 1 min at  
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11,000 x g. The flow-through is discarded and the NucleoSpin® Plasmid QuickPure 
Column is placed back into the collection tube.  
5. Buffer AQ is added to the tube (450 µl) and it is centrifuged for 3 min at 11,000 x g. 
6. The NucleoSpin® Plasmid QuickPure Column is placed in a 1.5 mL microcentrifuge 
tube and pure plasmid is eluted by the addition of 50 µL of Buffer AE. The tube is then 
incubated for 1 min at room temperature and centrifuged for 1 min at 11,000 x g. 
 
7.4. Creating Competent Cells 
1. Streak DH5α cells unto a SOB agar plate and allow to grow overnight (16-20 hours) at 
37˚C. 
 
2. Inoculate a single colony in 5 mL of SOB medium and grow the culture overnight (16-20 
hours). 
 
3. The following day, subculture the 5mL overnight culture into 50 mL of LB and allowed to 
for 90 min or until the culture reached OD600 of 0.3 to 0.5. 
 
4. Centrifuge the 50 mL culture for 15 min at 3000 g, 4˚C, discard the supernatant and 
resuspend the pellet gently in in ice cold 5 ml PIPES buffer. 
 
5. Incubate on ice for 20 min, centrifuge at 1000 g for 10 min at 4˚C, discard the 
supernatant and gently resuspend the pellet in 2 mL PIPES buffer 
Store the competent in 100µl aliquots 
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7.5. L-Lysine production pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.1. A simplified metabolic pathway of glycerol utilization to ε-PL production 
in S. albulus. The pathway involves the TCA which the carbon source such as glycerol 
enters. This is then converted into oxaloacetate, followed by L-aspartic acid. The L-
aspartic acid then undergoes a series of reactions to form L-lysine, whereby the Pls 
enzyme is involved in converting it into ε-PL (adapted from Hamano et al., 2007; Hamano 
et al., 2010). 
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7.6. Plasmid Maps 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2. The plasmids used to create a novel vector for gene knockouts in S. 
albulus.  (a) pIJ12551 plasmid containing the ermE* promoter. (b) pLAE001 plasmid 
containing the replicon region. (c) pACD4K-c containing the genes required for gene 
knockouts using group II introns. (Hamano et al., 2005; TargeTron® Gene knockout 
system user guide, 2013). 
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7.7. Statistical analysis 
 
Table A.1. Students t test for the significance of growth studies with P. 
simplissimum. 
 
 
 
 
 
 
 
 
The t stat value is greater than the t test which indicates a significant value at 95 % confidence 
level.  
 
 
Table A.2. Students t test for the significance of growth studies with A. niger. 
 
 
 
 
 
 
 
 
 
 
The t stat value is less than the t test which indicates no significant value at 95 % confidence level. 
  50 µg/mL 100 µg/mL 200 µg/mL 
Mean 46.85714286 46.85714286 46.85714286 
Variance 884.8928571 884.8928571 884.8928571 
Observations 7 7 7 
Pearson Correlation 0.980407575 0.984575526 0.961654685 
Hypothesized Mean Difference 0 0 0 
df 6 6 6 
t Stat 3.201475853 3.516521515 3.928956404 
P(T<=t) one-tail 0.009282732 0.006285745 0.003861002 
t Critical one-tail 1.943180281 1.943180281 1.943180281 
P(T<=t) two-tail 0.018565465 0.012571491 0.007722005 
t Critical two-tail 2.446911851 2.446911851 2.446911851 
  50 µg/mL 100 µg/mL 200 µg/mL 
Mean 25.5 25.5 25.5 
Variance 163.4166667 163.4166667 163.4166667 
Observations 7 7 7 
Pearson Correlation 0.971745614 0.981218494 0.980296505 
Hypothesized Mean 
Difference 0 0 0 
df 6 6 6 
t Stat 0.373785225 
-
1.942314387 
-
2.842450232 
P(T<=t) one-tail 0.360708078 0.050060061 0.014736016 
t Critical one-tail 1.943180281 1.943180281 1.943180281 
P(T<=t) two-tail 0.721416156 0.100120123 0.029472032 
t Critical two-tail 2.446911851 2.446911851 2.446911851 
